Congress of the International Society on Thrombosis and Haemostasis

Author Index

A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z

T
Taamma R.	-	MESOTHELIAL RAGE ACTIVATION BY AGES ENHANCES VEGF RELEASE AND POTENTIATES CAPILLARY TUBE FORMATION
Tabares A.H.	-	CLINICAL AUDIT OF THROMBOEMBOLISM PROPHYLAXIS 3 YEARS AFTER THE 6TH ACCP REPORT IN A TERTIARY CARE HOSPITAL FROM CRDOBA, ARGENTINA
Tabary N.	-	CUTANEOUS REACTION TO LOW MOLECULAR WEIGHT HEPARIN AND HOMOZYGOUSIS FOR FACTOR V LEIDEN MUTATION DURING PREGNANCY: A CASE REPORT
Tabata Y.	-	THROMBOMODULIN REGULATES GENE EXPRESSION OF ADHESION MOLECULES ON THE SURFACE OF ENDOTHELIAL CELLS EXPOSED TO HT1080 FIBROSARCOMA CELLS
Tabatabaei S.	-	HIGH PREVALENCE OF ELEVATED FACTOR VIII IN IRANIAN PATIENT WITH IDIOPATHIC VENOUS THROMBOEMBOLISM
Tabatabaey A.	-	GENETIC ANALYSIS OF PATIENTS WITH FACTOR XIII DEFICIENCY IN IRAN: REPORT OF FOUR NOVEL MUTATIONS
	-	FACTOR VII GENOTYPE AND CLINICAL PROFILE IN 6 IRANIAN PATIENTS WITH CONGENITAL FACTOR VII DEFICIENCY
Tabatabaie M.	-	THROMBOTIC EVENTS IN PATIENTS WITH ELEVATED FVIII LEVEL
Tabatabaie S.	-	THE PROTECTIVE EFFECT OF FXIII VAL34LEU POLYMORPHISM AGAINST VENOUS THROMBOSIS IN IRANIAN PATIENTS
Tabatabaii M.	-	HEREDITARY THROMBOPHILIC DEFECTS IN IRANIAN PATIENTS WITH CEREBRO VASCULAR ACCIDENT
	-	HEREDITARY DEFICIENCIES OF ANTITHROMBIN, PROTEIN S, AND THE PROTEIN C PATHWAY IN IRANIAN DVT PATIENTS
Taberna M.	-	CAN BLOOD HIPERVISCOSITY BE A PREDICTOR OF ACUTE CORONARY SYNDROME?
	-	ACUTE CORONARY SYNDROME AND MEAN PLATELET VOLUME
	-	DEFINITIVE PACEMAKER'S IN ANTICOAGULATED PATIENTS
Tabuchi A.	-	ASPIRIN EFFICACY: ANALYSIS OF WHOLE BLOOD-AGGREGATION USING THE SCREEN FILTRATION PRESSURE METHOD
Tacchi M.C.	-	ASSESSMENT OF THE EFFECTIVENESS AND SECURITY OF HOME TREATMENT OF DEEP VENOUS THROMBOSIS WITH LOW MOLECULAR WEIGHT HEPARIN IN ARGENTINA
Taddei S.	-	BETA-ADRENERGIC RECEPTORS MODULATION OF T-PA RELEASE VIA NO SYNTHASE-DEPENDENT PATHWAY IN NORMOTENSIVE SUBJECTS AND HYPERTENSIVE PATIENTS
	-	EPINEPHRINE INDUCES LOCAL T-PA RELEASE VIA A NITRIC OXIDE-DEPENDENT PATHWAY IN HUMAN FOREARM
	-	BILATERAL THROMBOSIS OF POSTERIOR SHORT CILIORETINAL VESSELS IN A PATIENTS WITH ANTIPHOSPHOLIPID SYNDROME, HYPERHOMOCYSTEINE AND ETEROZIGOUS FOR MTHRF
Tadokoro K.	-	PHYTOESTROGENS DOWN-REGULATE PROTEIN S EXPRESSION IN HEPG2 CELLS
Tadokoro S.	-	SEMAPHORIN 3A ANTAGONIZES AGONIST-INDUCED PI3 KINASE PATHWAY IN PLATELETS
Tadros R.	-	EVALUATION OF A PRE-TEST CLINICAL SCORE FOR THE DIAGNOSIS OF HIT
	-	NOVEL RISK FACTORS FOR DEEP VEIN THROMBOSIS IN HOSPITALIZED PATIENTS
Tadtaeva Z.G.	-	HOMOCYSTEINE LEVELS AND PREVALENCE OF C677T POLYMORPHISM IN METHYLENETETRAHYDROFOLATE REDUCTASE (MTHFR) GENE IN CHILDREN WITH MIGRAINE
Tagalakis V.	-	WARFARIN USE AND THE DECREASED RISK OF PROSTATE CANCER
	-	THE EFFECT OF ANTICOAGULANTS ON CANCER RISK AND SURVIVAL: SYSTEMATIC REVIEW
Tagariello G.	-	PRENATAL DIAGNOSIS OF HAEMOPHILIA A BY USING INTRON 1 INVERSION MUTATION
	-	UPDATE OF THE ITALIAN HAEMOPHILIA B MUTATION DATABASE
	-	FACTOR VIII (F8) GENE MUTATIONS AND IMMUNE TOLERANCE INDUCTION (ITI) IN HAEMOPHILIA A WITH INHIBITORS: DATA FROM THE ITALIAN ITI REGISTRY (THE PROFIT STUDY)
	-	PRIMARY KNEE ARTHOPLASTY USING RECOMBINANT FACTOR VIIA (RFVIIA) AS FIRST-LINE THERAPY IN HAEMOPHILIA PATIENTS WITH HIGH RESPONDING INHIBITORS
Taghavi A.	-	GENETIC ANALYSIS OF BERNARD SOULIER PATIENTS IN IRAN: REPORT OF FIVE NOVEL MUTATIONS
Tagle R.	-	TISSUE FACTOR-DEPENDENT COAGULANT ACTIVITY OF PLATELET-MONOCYTE COMPLEXES IN CHRONIC RENAL FAILURE (CRF). ASSOCIATION WITH HEMOSTATIC ACTIVITY, INFLAMMATION, OXIDATIVE DAMAGE AND ENDOTHELIAL DYSFUNCTION
Tagliabue L.	-	DATABASE ON RARE BLEEDING DISORDER (RBDS): PHENOTYPE AND GENOTYPE ANALYSIS ON 400 AFFECTED PATIENTS
Tagliaferri A.	-	A SUCCESSFUL IMMUNOMODULATION-ITI RESCUE IN SEVERE HAEMOPHILIA A WITH HIGH RESPONDER INHIBITOR
	-	THE HEMOPHILIA REGISTRY OF THE ITALIAN ASSOCIATION OF HEMOPHILIA CENTRES
	-	LONG-TERM PHARMACOVIGILANCE UPDATE WITH A RECOMBINANT FVIII CONCENTRATE FOR THE TREATMENT OF HEMOPHILIA A
	-	TEN NOVEL MUTATIONS IN FXI GENE
	-	IMMUNE TOLERANCE INDUCTION (ITI) IN PATIENTS WITH HEMOPHILIA A AND INHIBITORS: THE ITALIAN RETROSPECTIVE-PROSPECTIVE REGISTRY - THE PROFIT STUDY
Tagliavacca L.	-	ENDOTHELIAL PROTEIN C RECEPTOR EXPRESSION IN BREAST CANCER
Tagzirt M.	-	PLATELET FACTOR 4 (PF4/CXCL4) SEALS BLOOD CLOTS BY ALTERING THE STRUCTURE OF FIBRIN
Taha A.	-	PROTHROMBIN AND FACTOR V LEIDEN GENE POLYMORPHISM IN PATIENTS WITH DVT
Taher A.	-	ELEVATED LEVELS OF CIRCULATING PROCOAGULANT MICROPARTICLES IN PATIENTS WITH BETA-THALASSEMIA INTERMEDIA
Tailland M.L.	-	THE RISK OF UNEXPLAINED FOETAL LOSS IS DOSE-DEPENDENTLY RELATED TO THE EXPRESSION OF THE GLY219 VARIANT OF THE ENTOTHELIAL PROTEIN C RECEPTOR BY THE MOTHER, BY THE FATHER AND BY THE COUPLE
	-	ASYMPTOMATIC CARRIAGE OF THE JAK2V617F MUTATION IS ASSOCIATED WITH UNEXPLAINED EMBRYONIC AND FOETAL LOSS DURING THE FIRST PREGNANCY
Tait R.C.	-	MANAGEMENT OF AT ACTIVITY LEVELS WITH ANTITHROMBIN ALFA IN HEREDITARY AT DEFICIENT PATIENTS DURING SURGERY
Tait C.R.	-	A MUTATION IN EXON 27 OF THE VWF GENE CAUSING TYPE 2M AND TYPE 3 VON WILLEBRAND DISEASE IN THREE PATIENTS IN A FAMILY FROM THE WEST OF SCOTLAND
Tait R.C.	-	PREGNANT HEREDITARY ANTITHROMBIN DEFICIENT WOMEN REQUIRE A DISTINCT DOSING STRATEGY FOR THE MANAGEMENT OF AT ACTIVITY LEVELS WITH ANTITHROMBIN ALFA
	-	PREDICTING RISK OF RECURRENT VENOUS THROMBOSIS USING A 5-POINT SCORING SYSTEM INCLUDING FIBRIN D-DIMER
Tait C.	-	ANTICARDIOLIPIN ANTIBODIES AND OUTCOME OF PREGNANCY A RETROSPECTIVE 3 YEAR STUDY
Tait R.	-	POTENTIAL ROLE OF RAPID MOLECULAR SCREENING OF PATIENTS WITH DYSFIBRINOGENEMIA
	-	GENETIC ANALYSIS IN HYPOFIBRINOGENEMIA IN ELEVEN FAMILIES
Tajima K.	-	A COMPARATIVE EVALUATION OF THE CS-2000I COAGULATION ANALYSER USING CLOTTING, AMIDOLYTIC AND IMMUNO-TURBIDOMETRIC ASSAYS
Takac P.	-	VARIEGIN, A NOVEL CLASS OF THROMBIN INHIBITOR FROM THE SALIVARY GLAND EXTRACT OF THE HARD TICK AMBLYOMMA VARIEGATUM
Takagi A.	-	FOUR NOVEL CAUSATIVE MUTATIONS IDENTIFIED IN THE PROS1 GENE OF JAPANESE DEEP VEIN THROMBOSIS PATIENTS WITH PROTEIN S DEFICIENCY
	-	MOLECULAR BASIS OF ANTITHROMBIN DEFICIENCY IN FOUR JAPANESE PATIENTS WITH PREGNANCY-ASSOCIATED THROMBOSIS: ANTITHROMBIN GENE ABNORMALITIES INCLUDING TWO NOVEL MUTATIONS
	-	THE PROTEIN S THROMBIN SENSITIVE REGION CONTRIBUTES REGULATION OF WARFARIN TREATED DES-GAMMA-CARBOXYLATED PROTEIN S SECRETION: A STUDY OF A NOVEL SPLICE SITE MUTATION OF PROTEIN S GENE AND ITS MOLECULAR CONSEQUENCES
Takahari Y.	-	DISTINCT EFFECTS OF CYCLO-OXYGENASE (COX)-1 INHIBITOR OF ASPIRIN AND P2Y12 INHIBITOR OF CLOPIDOGREL ON THE THREE DIMENSIONAL GROWTH OF ARTERIAL THROMBI FORMED AT SITE OF FUNCTIONAL DAMAGE OF ENDOTHELIAL BY FECL3
Takahashi Y.	-	CONTINUOUS INFUSION OF VON WILLEBRAND FACTOR/FACTOR VIII CONCENTRATE IN PATIENTS WITH CONGENITAL VON WILLEBRAND DISEASE
Takahashi S.	-	GENETIC FACTORS FOR DETERMINATION OF PLASMA VWF LEVELS IN A GENERAL POPULATION
Takahashi M.	-	PLATELET IS AN IMPORTANT FACTOR IN VENOUS THROMBOEMBOLISM: INTERACTION OF VON WILLEBRAND FACTOR AND PLATELET GPIB PROMOTES VENOUS THROMBUS GROWTH
Takahashi N.	-	EFFECTS OF PITAVASTATIN AND EICOSAPENTAENOIC ACID ON PLATELET-DERIVED MICROPARTICLES AND ADIPONECTIN IN HYPERLIPIDEMIC PATIENTS WITH TYPE 2 DIABETES MELLITUS
Takahashi M.	-	MECHANISMS OF THROMBUS FORMATION DIFFER BETWEEN ATHEROSCLEROTIC AND NORMAL ARTERIES IN HYPERCHOLESTEROLEMIC RABBITS
Takahashi S.	-	THE PHARMACOLOGICAL PROFILE OF DZ-697B, A NOVEL ANTI-PLATELET AGENT
Takahashi H.	-	IN VIVO PHARMACOLOGICAL STUDIES OF AN ANTI-GPVI ANTIBODY THAT IMMUNODEPLETES GPVI WITHOUT PLATELET ACTIVATION
Takamatsu J.	-	THE PROTEIN S THROMBIN SENSITIVE REGION CONTRIBUTES REGULATION OF WARFARIN TREATED DES-GAMMA-CARBOXYLATED PROTEIN S SECRETION: A STUDY OF A NOVEL SPLICE SITE MUTATION OF PROTEIN S GENE AND ITS MOLECULAR CONSEQUENCES
Takamiya O.	-	FACTOR V DEFICIENCY DUE TO A NOVEL HOMOZYGOUS MUTATION: FV N468S, BUT NO BLEEDING TENDENCY
Takayama H.	-	INHIBITION OF CYTOSKELETAL ASSEMBLY BY CYTOCHALASIN D PREVENTS ENLARGEMENT OF RAFTS ACCOMPANIED BY GPVI ACCUMULATION IN COLLAGEN-STIMULATED PLATELETS
	-	IN VIVO PHARMACOLOGICAL STUDIES OF AN ANTI-GPVI ANTIBODY THAT IMMUNODEPLETES GPVI WITHOUT PLATELET ACTIVATION
Takei R.	-	EXTRACTS OF AN EDIBLE MUSHROOM WITH ANTITHROMBIN III-INDEPENDENT ANTICOAGULANT ACTIVITY
Takeoka S.	-	HEMOSTATIC EFFECTS OF LIPOSOMES CARRYING FIBRINOGEN GAMMA-CHAIN DODECAPEPTIDE AS A PLATELET SUBSTITUTE
	-	HEMOSTATIC EFFECTS OF LIPOSOMES CARRYING FIBRINOGEN GAMMA-CHAIN DODECAPEPTIDE AND ENCAPSULATING ADENOSINE 5'-DIPHOSPHATE AS A PLATELET SUBSTITUTE
	-	PROLONGED HEMOSTATIC ABILITY OF POLY(ETHYLENE GLYCOL)-MODIFIED POLYMERIZED ALBUMIN PARTICLES CARRYING FIBRINOGEN-GAMMA CHAIN DODECAPEPTIDE
Takeshita S.	-	A LARGE DELETION OF THE PROS1 GENE IN A DEEP VEIN THROMBOSIS PATIENT WITH PROTEIN S DEFICIENCY
	-	ONE-THIRD OF JAPANESE PATIENTS WITH DEEP VEIN THROMBOSIS CARRIED THE GENETIC MUTATIONS IN PROTEINS S, C AND ANTITHROMBIN GENES: THE SUB-GROUP STUDY OF BLOOD COAGULATION ABNORMALITY, THE STUDY GROUP OF RESEARCH ON MEASURES FOR INTRACTABLE DISEASES IN JAPAN
Taketomi T.	-	HEMOSTATIC RESPONSES TO RECOMBINANT ACTIVATED FACTOR VII IN THE PRESENCE OF ANTITHROMBIN DEFICIENCY
Takeuchi M.	-	DOES DIFFERENT D-DIMER LEVEL REDUCE THE USE OF VENOUS DUPLEX SCANNING TO RULE OUT DEEP VEIN THROMBOSIS IN PATIENTS WITH SYMPTOMATIC PULMONARY EMBOLISM?
	-	THE UTILITY OF QUANTITATIVE CALF MUSCLE NEARINFRARED SPECTROSCOPY IN THE FOLLOWUP OF ACUTE DEEP VEIN THROMBOSIS
	-	PREVALENCE AND DISTRIBUTION OF DEEP VEIN THROMBOSIS IN PATIENTS WITH SYMPTOMATIC PULMONARY EMBOLISM
Takeya H.	-	IDENTIFICATION OF MULTIPLE SPLICE VARIANTS OF PHOSPHOLIPID SCRAMBLASE 1
	-	CLUSTERING OF SURFACE-BOUND BETA2-GLYCOPROTEIN I
Takiuchi S.	-	GENETIC POLYMORPHISMS OF ENDOTHELIN CONVERTING ENZYME-1 GENE ASSOCIATED WITH HYPERTENSION IN A JAPANESE POPULATION AND A NOVEL MISSENSE MUTATION IN PREPROENDOTHELIN-1 IN A JAPANESE HYPERTENSIVE
Takizawa H.	-	AN ULTRA SENSITIVE ASSAY FOR THE QUANTIFICATION OF GPVI SHEDDING IN HUMAN PLASMA
	-	MURINE GPVI ANTIBODY DOES NOT INDUCE GPVI-DEPLETION BUT REDUCES IN VIVO THROMBOSIS WITH MINIMAL BLEEDING RISK IN RATS
	-	FUNCTIONAL ANALYSIS OF ANTI-GPVI MONOCLONAL ANTIBODIES WITH DISTINCT BINDING SITES
Takla A.	-	PHYSICAL EXAMINATION IN PATIENTS WITH SEVERE HEMOPHILIA UNDER PROPHYLACTIC TREATMENT - EFFICACY OF AN EARLY LONG-TERM PROPHYLAXIS?
Talbot K.	-	HOMOZYGOUS FACTOR V DEFICIENCY WITH MILD CLINICAL PHENOTYPE
	-	PROTEOLYTIC CONVERSION OF CLOTTING FACTOR XA INTO A FIBRINOLYSIS ACCELERATOR
Taleb S.	-	ELEVATED LEVELS OF CIRCULATING PROCOAGULANT MICROPARTICLES IN PATIENTS WITH BETA-THALASSEMIA INTERMEDIA
Talebian A.	-	HEREDITARY THROMBOPHILIC DEFECTS IN IRANIAN PATIENTS WITH CEREBRO VASCULAR ACCIDENT
	-	HEREDITARY DEFICIENCIES OF ANTITHROMBIN, PROTEIN S, AND THE PROTEIN C PATHWAY IN IRANIAN DVT PATIENTS
Tamaddon G.	-	GENETIC ANALYSIS OF PATIENTS WITH FACTOR XIII DEFICIENCY IN IRAN: REPORT OF FOUR NOVEL MUTATIONS
Tamaki S.	-	ALTERNATION OF VON WILLEBRAND FACTOR AND ADAMTS13 ACTIVITY AND ITS CLINICAL SIGNIFICANCE IN PATIENTS WITH OBSTRUCTIVE SLEEP APNEA SYNDROME
Tamari T.	-	THE ROLE OF MICROPARTICLES IN GESTATIONAL VASCULAR COMPLICATIONS
	-	MICROPARTICLES' INDUCE PRO-COAGULANT AND APOPTOTIC EFFECTS ON ENDOTHELIAL CELLS
Tamarin I.	-	CAN THROMBIN GENERATION (TG) BE USED TO MONITOR RFVIIA TREATMENT: IN VIVO "MINI-PK" STUDY IN HEMOPHILIA A PATIENTS
	-	PERINATAL ISCHEMIC STROKE AND THE INCIDENCE OF MATERNAL AND NEONATAL THROMBOPHILIA
Tamary H.	-	ISRAELI PEDIATRIC ONCOLOGY REGISTRY ON CENTRAL VENOUS LINE RELATED COMPLICATIONS
Tambaro R.	-	A PROPOSAL OF SCORING SYSTEM IN ASSESSMENT OF THROMBOTIC RISK IN CANCER PATIENT. A MONOCENTRIC STUDY
Tambourgi T.D.V.	-	PLASMA INCOAGULABILITY INDUCED BY LONOMIA OBLIQUA BRISTLE EXTRACT IS ASSOCIATED WITH THE ABUNDANT PRESENCE OF LIPOCALINS
Tambunan K.	-	ANTIPHOSPHOLIPID ANTIBODIES IN ADULT -THALASSEMIA
	-	POTENTIAL FACTORS WHICH MAY CAUSE A HIGH LEVEL OF ACA IGG AND IGM
	-	CORRELATION BETWEEN A HIGHER LEVEL OF ACA WITH THE HEMOSTASIS ABNORMALITIES AMONG ADULT -THALASSEMIA
Tamimoto S.	-	CLINICAL SIGNIFICANCE OF HMGB-1, SF AND PAI-1 AS A VITAL- PROGNOSIS MARKER
Tamsma J.T.	-	HIGH LEVELS OF LDL-CHOLESTEROL AND TRIGLYCERIDES AND SUBOPTIMAL GLYCEMIC CONTROL PREDICT DIMINISHED EX VIVO ASPIRIN RESPONSIVENESS IN PATIENTS WITH TYPE 2 DIABETES
Tamura N.	-	A ROLE FOR GEMS IN PLATELET GLYCOPROTEIN IB-MEDIATED PLATELET ACTIVATION
	-	FUNCTIONAL REGULATION OF VON WILLEBRAND FACTOR ON THE FORMATION OF PLATELET THROMBI UNDER BLOOD FLOW CONDITION BY ITS SPECIFIC CLEAVING PROTEASE OF ADAMTS13
Tamura A.	-	CHARACTERIZATION OF A LARGE DELETION THAT LEADS TO CONGENITAL FACTOR XIII DEFICIENCY
	-	CONTINUOUS INFUSION OF VON WILLEBRAND FACTOR/FACTOR VIII CONCENTRATE IN PATIENTS WITH CONGENITAL VON WILLEBRAND DISEASE
Tamura N.	-	CONTRIBUTION OF FACTOR XA (FXA) IN THE THREE DIMENSIONAL GROWTH OF PLATELET THROMBI FORMED ON COLLAGEN FIBRILS UNDER BLOOD FLOW CONDITIONS
	-	ADAMTS-13 WITHIN THROMBUS DOWN-REGULATES THROMBUS FORMATION UNDER FLOW CONDITIONS
Tan K.	-	GENETIC MODIFICATION OF A SPECIES-DIVERGENT BOND IN VWF-A1 PEMITS HUMAN PLATELET THROMBUS FORMATION IN MICE
Tan M.A.	-	OCCIPITAL BONE COMPRESSION OF THE SUPERIOR SAGITTAL SINUS AS A CONTRIBUTORY FACTOR IN NEONATAL CEREBRAL SINOVENOUS THROMBOSIS
Tanaka A.	-	CONTINUOUS INFUSION OF VON WILLEBRAND FACTOR/FACTOR VIII CONCENTRATE IN PATIENTS WITH CONGENITAL VON WILLEBRAND DISEASE
Tanaka S.	-	PHOSPHOINOSITIDE 3-KINASE-INDUCED CYTOSKELETAL TRANSLOCATION OF PROTEIN KINASE CK2 IN THROMBIN-STIMULATED PLATELETS
Tanaka E.	-	MULTIMODALITY INTRAOPERATIVE IMAGING OF THROMBI IN THICK-WALLED BLOOD VESSELS OF LARGE ANIMALS USING NEAR INFRARED FLUORESCENCE
Tanaka M.	-	EFFECT OF SYNTHETIC PEPTIDES DERIVED FROM STAPHYLOKINASE ON THE ACTIVATION OF PLASMINOGEN
Tanaka C.	-	GENETIC POLYMORPHISMS OF ENDOTHELIN CONVERTING ENZYME-1 GENE ASSOCIATED WITH HYPERTENSION IN A JAPANESE POPULATION AND A NOVEL MISSENSE MUTATION IN PREPROENDOTHELIN-1 IN A JAPANESE HYPERTENSIVE
Tanaka A.	-	EFFECTS OF PITAVASTATIN AND EICOSAPENTAENOIC ACID ON PLATELET-DERIVED MICROPARTICLES AND ADIPONECTIN IN HYPERLIPIDEMIC PATIENTS WITH TYPE 2 DIABETES MELLITUS
Tanaka K.A.	-	HEMOSTATIC RESPONSES TO RECOMBINANT ACTIVATED FACTOR VII IN THE PRESENCE OF ANTITHROMBIN DEFICIENCY
Tanaka S.	-	LIPID RAFT-DEPENDENT ACTIVATION OF NOVEL 33-KDA SER/THR KINASE IN THROMBIN-STIMULATED PLATELETS
Tanaka F.	-	PLATELET VOLUME IN CORD BLOOD
Tanck M.W.T.	-	DETERMINANTS OF THE ENDOGENOUS THROMBIN POTENTIAL IN A DUTCH THROMBOPHILIC FAMILY
Tandon N.N.	-	FUNCTIONAL ANALYSIS OF ANTI-GPVI MONOCLONAL ANTIBODIES WITH DISTINCT BINDING SITES
	-	MURINE GPVI ANTIBODY DOES NOT INDUCE GPVI-DEPLETION BUT REDUCES IN VIVO THROMBOSIS WITH MINIMAL BLEEDING RISK IN RATS
	-	AN ULTRA SENSITIVE ASSAY FOR THE QUANTIFICATION OF GPVI SHEDDING IN HUMAN PLASMA
Taner M.	-	RADIOISOTOPE SYNOVECTOMY WITH RHENIUM 186 FOR TREATMENT OF HEMOPHILIC SYNOVITIS
Tang X.	-	SIGNAL TRANSDUCTION PATHWAYS OF INTERLEUKIN-6 INDUCING TISSUE FACTOR EXPRESSION IN VASCULAR ENDOTHELIAL CELLS
Tang B.N.T.	-	USEFULNESS OF PERFUSION LUNG SCAN COMBINED WITH CLINICAL ASSESSMENT TO RULE OUT PULMONARY EMBOLISM
Tang L.	-	PEGYLATION PROTECTS FACTOR VIII FROM THE INHIBITION OF ANTIBODY INHIBITORS
	-	BIOLOGICAL ACTIVITY OF PEGYLATED FACTOR VIII
	-	MUTATIONS AT THE LOW-DENSITY LIPOPROTEIN RECEPTOR-RELATED PROTEIN (LRP) BINDING SITE OF THE FVIII A2 DOMAIN DID NOT REDUCE LRP BINDING OR INCREASE HALF-LIFE OF NON-ACTIVATED FVIII
Tang X.	-	EFFECT OF TETRAMETHYLPYRAZINE ON THE EXPRESSION OF TISSUE FACTOR INDUCED BY THROMBIN AND ITS MECHANISM
Tang L.	-	SITE-SPECIFIC PEGYLATION OF RFVIII RESULTS IN PROLONGED IN VIVO EFFICACY
Taniguchi R.	-	ASPIRIN EFFICACY: ANALYSIS OF WHOLE BLOOD-AGGREGATION USING THE SCREEN FILTRATION PRESSURE METHOD
Tankiewicz-Kwedlo A.	-	PLASMIN SYSTEM REGULATION IN OVA-SENSITIZED RAT MODEL OF ASTHMA
Tans G.	-	MEASUREMENT OF THROMBIN GENERATION AND APC-RESISTANCE IN MOUSE PLASMA
	-	THE ROLE OF THROMBIN EXOSITES I AND II IN THE ACTIVATION OF HUMAN COAGULATION FACTOR V
	-	EFFECT OF ORAL CONTRACEPTIVES ON THROMBIN GENERATION MEASURED VIA CALIBRATED AUTOMATED THROMBOGRAPHY
	-	PROTEIN S-C4BP COMPLEX STIMULATES ACTIVATED PROTEIN C-MEDIATED INACTIVATION AT R306 BUT INHIBITS INACTIVATION AT R506 IN FACTOR VA
Tantry U.S.	-	MYONECROSIS IS PREDICTED BY HIGH REACTIVITY TO MULTIPLE PLATELET AGONISTS: A TRANSLATIONAL STUDY OF PATIENTS UNDERGOING STENTING TREATED WITH BIVALIRUDIN AND HIGH DOSE CLOPIDOGREL
	-	PLATELET FUNCTION MEASURED BY VERIFYNOW IDENTIFIES GENERALIZED HIGH PLATELET REACTIVITY IN ASPIRIN TREATED PATIENTS
	-	TRANSITION TO AN UNSTABLE CORONARY SYNDROME IS MARKED BY HYPERCOAGUABILITY, PLATELET ACTIVATION, HEIGHTENED PLATELET REACTIVITY, AND INFLAMMATION: RESULTS OF THE THROMBOTIC RISK PROGRESSION (TRIP) STUDY
	-	IS THE ASSESSMENT OF CLOPIDOGREL RESPONSIVENESS AFFECTED BY THE ANTICOAGULANT OR MEASUREMENT OF MAXIMUM PLATELET AGGREGATION OR FINAL PLATELET AGGREGATION?
Tantry U.	-	SYNERGISTIC EFFECT OF SMOKING ON PLATELET RESPONSIVENESS TO CLOPIDOGREL
Tantry U.S.	-	POST - CORONARY INTERVENTION RECURRENT ISCHEMIA IN THE PRESENCE OF ADEQUATE PLATELET INHIBITION BY DUAL ANTIPLATELET THERAPY: WHAT ARE WE OVERLOOKING?
	-	THE RELATION OF HIGH EX VIVO THROMBOGENIC POTENTIAL TO HIGH ISCHEMIC RISK IN AFRICAN AMERICAN WOMEN UNDERGOING CORONARY STENTING
	-	SUPERIOR EFFECT OF EPTIFIBATIDE ADDED TO CLOPIDOGREL ON BIOMARKER EXPRESSION DETECTED BY FLUOROKINE MULTI-ANALYTE PROFILING IN PATIENTS UNDERGOING ELECTIVE PCI
	-	BIOMARKER ANALYSIS BY FLUOROKINE MULTI-ANALYTE PROFILING DISTINGUISHES PATIENTS REQUIRING INTERVENTION FROM PATIENTS WITH LONG-TERM QUIESCENT CORONARY ARTERY DISEASE: A POTENTIAL APPROACH TO IDENTIFY ATHEROSCLEROTIC DISEASE PROGRESSION
	-	RELATION OF PLATELET-FIBRIN CLOT STRENGTH, PLATELET REACTIVITY, INFLAMMATION AND GROWTH FACTOR RELEASE TO THROMBOTIC RISK IN PATIENTS UNDERGOING STENTING
	-	EFFECTS OF DIABETES ON THE PREVALENCE OF ASPIRIN RESISTANCE DURING LOW DOSE ASPIRIN THERAPY
	-	VULNERABLE BLOOD MEASURED BY THROMBELASTOGRAPHY: A PREDICTOR OF TARGET LESION REVASCULARIZATION AFTER CORONARY STENTING
	-	DO WE COMPLETELY UNDERSTAND THE ANTITHROMBOTIC EFFECT OF ASPIRIN?
	-	EFFECT OF BIVALIRUDIN VS. BIVALIRUDIN WITH EPTIFIBATIDE ON PLATELET ACTIVATION AND AGGREGATION IN PATIENTS RECEIVING CHRONIC CLOPIDOGREL THERAPY UNDERGOING ELECTIVE PCI
	-	LATE BREAKING CLINICAL TRIAL: BIVALIRUDIN WITH AND WITHOUT EPTIFIBATIDE FOR ELECTIVE STENTING: A PHARMACODYNAMIC STUDY OF PLATELET REACTIVITY IN RELATION TO THE OCCURRENCE OF PERIPROCEDURAL MYOCARDIAL INFARCTION (THE CLEAR PLATELETS-2 STUDY)
	-	INHIBITION OF PLATELET AGGREGATION: A NOVEL EFFECT OF C-REACTIVE PROTEIN
	-	PATIENTS WITH METABOLIC SYNDROME DEMONSTRATE HIGH PLATELET REACTIVITY AND INCREASED PROCOAGULANT MARKERS
Tao J.	-	CD72 POLYMORPHISM ASSOCIATED WITH SUSCEPTIBILITY TO IDIOPATHIC THROMBOCYTOPENIA PURPURA IN CHINESE PATIENTS
	-	THE HUMAN DNMTS1,3A AND 3B MRNA EXPRESSION IN ADULT ITP PATIENTS
Tao Z.	-	SHEAR-INDUCED DISULFIDE BOND FORMATION REGULATES ADHESION ACTIVITY OF VON WILLEBRAND FACTOR
Tao H.	-	SCREENING FOR OCCULT MALIGNANCY IN PATIENTS WITH IDIOPATHIC VENOUS THROMBOEMBOLISM (VTE) EVALUATION (SOME TRIAL): A PROSPECTIVE PILOT COHORT STUDY USING COMPREHENSIVE ABDOMEN/PELVIS COMPUTED TOMOGRAPHY (CCT)
Tao L.	-	EPITOPE MAPPING OF COLLAGEN BINDING SITE IN HUMAN GLYCOPROTEIN VI (GPVI)
Taouli K.K.T.	-	SEVERE HYPOFIBRINOGENEMIA ASSOCIATED WITH MIDDLE CEREBRAL ARTERIAL THROMBOSIS
Taouli K.	-	ANTIPHOSPHOLIPID ANTIBODIES AND THE ANTIPHOSPHOLIPID SYNDROME IN PATIENTS WITH SYSTEMIC LUPUS RYTHMATOSUS
Tapon-Bretaudière J.	-	SOURCE OF TISSUE FACTOR LEADING TO DISCREPANT PLASMA FVII LEVELS IN EIGHT FVII-DEFICIENT PATIENTS OF AFRICAN ORIGIN
	-	A 2 ADENINE INSERTION POLYMORPHISM IN THE FVII GENE 3'UTR IS ASSOCIATED WITH PERIPHERAL ARTERIAL DISEASE BUT NOT WITH VENOUS THROMBOSIS: RESULTS OF CASE-CONTROL STUDIES
	-	SEVERE FACTOR VII DEFICIENCY DUE TO MUTATIONS IN THE FACTOR VII GENE PROMOTER
Tappenden K.A.	-	HUMAN VASCULAR ENDOTHELIAL CELLS INFLUENCE THE WHOLE BLOOD THROMBIN GENERATION ASSAY
	-	WHOLE BLOOD AND PLASMA THROMBIN GENERATION ASSAYS IN PATIENTS WITH A HISTORY OF VENOUS THROMBOEMBOLISM
Tapson V.F.	-	LATE BREAKING CLINICAL TRIAL: A LARGE-SCALE, GLOBAL OBSERVATIONAL STUDY OF VENOUS THROMBOEMBOLISM RISK AND PROPHYLAXIS IN THE ACUTE HOSPITAL CARE SETTING: THE ENDORSE STUDY
	-	LATE BREAKING CLINICAL TRIAL: EXTENDED-DURATION VENOUS THROMBOEMBOLISM (VTE) PROPHYLAXIS IN ACUTELY ILL MEDICAL PATIENTS WITH RECENT REDUCED MOBILITY: THE EXCLAIM STUDY
Tarantino M.	-	U.S. INHIBITOR PILOT PROJECT: STUDY DESIGN AND METHODS VALIDATION
Tarantino M.D.	-	THE ROLE OF FC-GAMMA RECEPTOR GENE POLYMORPHISMS IN THE CLINICAL OUTCOME OF NEWLY DIAGNOSED ITP IN CHILDREN
Tarantul V.Z.	-	EXPERIMENTAL MODEL OF THROMBOSIS IN RABBIT'S MARGINAL EAR VEIN
Tardy B.	-	ORGARAN CROSS REACTIVITY WITH HEPARIN INDUCED THROMBOCYTOPENIA ANTIBODIES: REPORT OF 12 CASES
	-	EVOLUTION OF D-DIMERS LEVELS DURING HEPARIN THERAPY OF PATIENTS WITH CEREBRAL VENOUS THROMBOSIS
	-	IN VITRO EFFECTS OF LEPIRUDINE, DANAPAROID AND FONDAPARINUX ON THROMBIN GENERATION IN HIT PLASMAS
Tardy-Poncet B.	-	IN VITRO EFFECTS OF LEPIRUDINE, DANAPAROID AND FONDAPARINUX ON THROMBIN GENERATION IN HIT PLASMAS
	-	EVOLUTION OF D-DIMERS LEVELS DURING HEPARIN THERAPY OF PATIENTS WITH CEREBRAL VENOUS THROMBOSIS
	-	ORGARAN CROSS REACTIVITY WITH HEPARIN INDUCED THROMBOCYTOPENIA ANTIBODIES: REPORT OF 12 CASES
	-	TFPI LEVELS AND HAEMORRHAGIC EVENTS IN HAEMOPHILIC PATIENTS
Targhetta R.	-	EFFICACY AND SAFETY OF HIGHLY PURIFIED VWF/FVIII CONCENTRATES IN THE TREATMENT OF INHERITED VON WILLEBRAND DISEASE: RESULTS FROM THE RETROSPECTIVE ITALIAN STUDY ON 103 CASES
Tarkovskaya L.R.	-	INFLUENCE OF HYPERHOMOCYSTEINEMIA ON FIBRINOLYTIC AND ANTICOAGULANT SYSTEMS IN PATIENTS WITH ACUTE CORONARY SYNDROME
Tarnow I.	-	CYSTIC FIBROSIS HETEROZYGOTES DO NOT HAVE INCREASED PLATELET ACTIVATION
Tasdemir H.	-	CEREBRAL THROMBOSIS ASSOCIATED WITH HETEROZYGOUS FV LEIDEN MUTATION AND HIGH LIPOPROTEIN A LEVEL IN A GIRL WITH FACTOR XIII DEFICIENCY
Tashiro H.	-	INCREASED THROMBIN GENERATION CAPACITY IN SEPTIC PATIENTS WITH DIC
	-	INCREASED LEVELS OF D-DIMER IN PATIENTS WITH MYOCARDIAL INFARCTION
Tasneem S.	-	THE ROLE OF THE FACTOR V B DOMAIN IN FACTOR V-MMRN1 BINDING AND DISSOCIATION
	-	PLATELET FACTOR V DEFICIENCY IN A PATIENT WITH AN ACQUIRED INHIBITOR OF VA PROCOAGULANT FUNCTION
Tassan R.	-	A NOVEL FLOW CYTOMETRIC METHOD FOR THE DETECTION OF RETICULATED PLATELETS BY AN ANTI-BROMODEOXYURIDINE MONOCLONAL ANTIBODY
Tassies D.	-	THE GENOTYPE BC OF THE VNTR POLIMORPHISM OF THE PLATELET GLYCOPROTEIN IB-ALPHA IS RELATED TO ASPIRIN TREATMENT FAILURE IN PATIENTS WITH ISCHEMIC STROKE
	-	CANCER AND VENOUS THROMBOEMBOLISM: ROLE OF GENETIC POLYMORPHISMS IN SELECTINS AND TISSUE FACTOR
	-	THROMBIN GENERATION IN BEHET'S DISEASE: RELATIONSHIP WITH THROMBOSIS
	-	VENOUS THROMBOEMBOLISM IN YOUNG PATIENTS: ROLE OF GENETIC POLYMORPHISMS IN SELECTINS AND TISSUE FACTOR
Tassinari C.	-	UPDATE OF THE ITALIAN HAEMOPHILIA B MUTATION DATABASE
	-	PRENATAL DIAGNOSIS OF HAEMOPHILIA A BY USING INTRON 1 INVERSION MUTATION
Tatarova N.N.	-	PREVALENCE OF HYPERHOMOCYSTEINEMIA IN WOMEN WITH PREMENSTRUAL SYNDROME AND EFFECT OF ORAL AND VAGINAL DELIVERY OF ETHINYL ESTRADIOL AND DEZOGESTREL ON HOMOCYSTEINE LEVELS
Tatasciore A.	-	INHIBITORY EFFECT OF COFFEE ON PLATELET AGGREGATION
Taube T.	-	SUCCESSFUL IMMUNE TOLERANCE INDUCTION (ITI) OF HIGH-RESPONDING INHIBITORS WITH A HIGH PURITY FVIII/VWF CONCENTRATE
Taubert D.	-	IMPAIRED EFFICACY OF CLOPIDOGREL IN PATIENTS WITH A ST-SEGMENT ELEVATION MYOCARDIAL INFARCTION
Taubman M.B.	-	SMOOTH MUSCLE-DERIVED TISSUE FACTOR IS CRITICAL FOR ARTERIAL THROMBOSIS AFTER FECL3 INJURY
Tauzin L.	-	PRETERM BIRTH AND FETAL GROWTH RESTRICTION HAVE AN IMPACT ON ELASTIC AND COLLAGENIC STRUCTURES OF HUMAN UMBILICAL ARTERIES
Tavafoghi M.	-	INFLUENCE OF INHERITED THROMBOPHILIA WITH RECURRENT PREGNANCY LOSS
Tavasoli F.	-	HIGH PREVALENCE OF ELEVATED FACTOR VIII IN IRANIAN PATIENT WITH IDIOPATHIC VENOUS THROMBOEMBOLISM
Taverna M.	-	IN VIVO-ASSAY FOR WARFARIN-RESISTANCE BY COEXPRESSION OF VKORC1 AND VITAMIN K-DEPENDENT COAGULATION FACTORS
Tavil B.	-	RISK FACTORS AND OUTCOME OF PEDIATRIC THROMBOTIC EPISODES IN A SINGLE CENTER
Tay L.	-	A COMPARATIVE STUDY OF LOW MOLECULAR WEIGHT HEPARIN (LMWH) MONITORING BY ANTI-XA LEVELS, OVERALL HAEMOSTASIS POTENTIAL (OHP) AND CALIBRATED AUTOMATED THROMBOGRAM (CAT) ASSAYS
Taylor J.	-	AUDIT OF SCREENING FOR VON WILLEBRANDS DISEASE AND PLATELET FUNCTION ABNORMALITIES USING THE PFA-100
Taylor F.B.	-	GENOMIC AND STRUCTURAL ANALYSIS OF THE PROTECTIVE EFFECTS OF ACTIVATED PROTEIN C IN A BABOON MODEL OF E. COLI SEPSIS
Taylor Jr. F.B.	-	A NEW LOOK AT THE PATHOPHYSIOLOGICAL PROCESSES, STAGING AND DIAGNOSIS OF SEVERE SEPSIS (TRANSLATION FROM PRECLINICAL STUDIES IN PRIMATES TO PATIENTS WITH SEVERE SEPSIS
Tayo B.	-	INTERLEUKINS GENES TAG-SNP HAPLOTYPES AND RISK OF MYOCARDIAL INFARCTION: A POPULATION BASED CASE-CONTROL STUDY
Tchaikovski S.N.	-	MEASUREMENT OF THROMBIN GENERATION AND APC-RESISTANCE IN MOUSE PLASMA
	-	EFFECT OF ORAL CONTRACEPTIVES ON THROMBIN GENERATION MEASURED VIA CALIBRATED AUTOMATED THROMBOGRAPHY
Tcherniantchouk O.	-	CORRELATION OF PF4 ELISA (PF4) OPTICAL DENSITY RESULTS AND CLINICAL FINDINGS TO ACCURATELY DIAGNOSE HEPARIN INDUCED THROMBOCYTOPENIA (HIT)
Tchernychev B.	-	PHARMACOLOGICAL TARGETING OF PLATELETS BY ORALLY ACTIVE PI3-KINASE B INHIBITOR PROTECTS AGAINST ARTERIAL THROMBOSIS
Teare J.	-	SITE-SPECIFIC PEGYLATION OF RFVIII RESULTS IN PROLONGED IN VIVO EFFICACY
	-	BIOLOGICAL ACTIVITY OF PEGYLATED FACTOR VIII
Tebbe U.	-	CERTIFY, A PHASE III STUDY COMPARING CERTOPARIN WITH UNFRACTIONATED HEPARIN IN ELDERLY, ACUTELY ILL MEDICAL PATIENTS
Tedgard U.	-	ANTI-PROTEIN S ANTIBODIES IN CHILDREN WITH PURPURA FULMINANS AND IN HEALTHY CHILDREN FOLLOWING VARICELLA AS WELL AS IN CHILDREN WITH THROMBOSIS
Tedgui A.	-	HCAN CHANGES IN HEMOSTATIC PARAMETERS EXPLAIN THE INCREASED INCIDENCE OF DVT IN ELDERLY ?
	-	CD36 AND SRA GENE EXPRESSION IN HUMAN CAROTID ENDARTERECTOMY LESIONS
Teerajetgul Y.	-	COMPARATIVE STUDY OF THE EFFECTS OF NATURAL HONEY, SESAME OIL, AND SOY MILK CONSUMPTION ON BLOOD LEVEL OF LIPID PEROXIDATION AND TOTAL PHENOLIC COMPOUNDS
Teitel J.	-	FACTOR XI (FXI) IS PRESENT IN ANTI-D PREPARATIONS AND CAN INDUCE AN INHIBITOR TO FXI IN PATIENTS WITH SEVERE FXI DEFICIENCY
Teitel J.M.	-	HEMOSTASIS IN FACTOR VIII DEFICIENT MICE IS IMPROVED AFTER THE INFUSION OF MONOCYTE-DERIVED MICROPARTICLES
Teitel J.	-	BERNARD-SOULIER PLATELETS EXPOSE MORE PROCOAGULANT PHOSPHATIDYLSERINE (PS), WITH PAR1 AND PAR4 MEDIATING THE SYNERGISTIC EFFECT OF THROMBIN ON COLLAGEN-STIMULATED PS EXPRESSION
Tekelenburg W.	-	DIMERIC 2-GPI BINDS TO LDL-BINDING DOMAIN 1 OF APOER2. PLATELETS EXPRESS THREE 3 DIFFERENT SPLICE VARIANTS OF APOER2 OF WHICH APOER24-5 IS THE MOST ABUNDANT
Tekgunduz E.	-	INCIDENCE OF ANTI-HEPARIN/PLATELET FACTOR 4 (AHPF4) ANTIBODIES AND HEPARIN-INDUCED THROMBOCYTOPENIA (HIT) IN MEDICAL PATIENTS
	-	IS PLATELET HYPERREACTIVITY DEFINING STICKY PLATELET SYNDROME A GLOBAL PHENOMENON? THE STUDY OF DETERMINATON OF NORMAL VALUES IN TURKISH HEALTHY SUBJECTS
	-	LONGITUDINAL OBSERVATION OF TAFI LEVELS ALONG NORMAL PREGNANCY AND PUERPERIUM: RELATIONSHIP BETWEEN TAFI AND OTHER MARKERS OF FIBRINOLYSIS
Tellier M.	-	CONTRIBUTION OF CHROMATOGRAPHY STEPS IN PRION REMOVAL IN PLASMA-DERIVED PRODUCT MANUFACTURING
Tellier Z.	-	FINAL RESULTS OF A PROSPECTIVE-MULTICENTRE STUDY TO EVALUATE PHARMACOKINETICS, EFFICACY AND SAFETY OF A SOLVENT-DETERGENT TREATED AND 15 NANOMETER-FILTERED PLASMA-DERIVED FACTOR VIII
Tellier M.	-	EFFICIENT PRION REMOVAL DURING THE MANUFACTURING PROCESS OF BETAFACT, A HIGH-PURITY PLASMA DERIVED FACTOR IX
Tellier Z.	-	COMPARISON OF THE IMMUNOGENICITY OF DIFFERENT THERAPEUTIC PREPARATIONS OF HUMAN FACTOR VIII IN THE MURINE MODEL OF HEMOPHILIA A
	-	FINAL ANALYSIS OF A PROSPECTIVE-MULTICENTRE STUDY TO EVALUATE EFFICACY AND SAFETY OF A TRIPLE-SECURED VON WILLEBRAND FACTOR (VWF)
Temal C.	-	ESTABLISHING REFERENCE VALUES FOR COAGULATION PARAMETERS IN PREGNANT WOMEN
Tembl J.	-	DUAL ANTIPLATELET THERAPY WITH CLOPIDOGREL AND ASPIRIN ATTENUATES PLATELET REACTIVITY AND PROTHROMBOTIC EFFECT OF ERYTHROCYTES IN PATIENTS AFTER CAROTID STENTING
Temble J.	-	EARLY TISSUE FACTOR-INDUCED THROMBIN GENERATION IN PLATELETS: INFLUENCE OF ASPIRIN AND ASPIRIN PLUS CLOPIDOGREL
ten Berg J.M.	-	IMPAIRED EFFICACY OF CLOPIDOGREL IN PATIENTS WITH A ST-SEGMENT ELEVATION MYOCARDIAL INFARCTION
	-	COMPARISON OF A NEW CARTRIDGE* FOR THE PFA-100 WITH OTHER PLATELET FUNCTION ASSAYS FOR MEASURING THE EFFECT OF CLOPIDOGREL THERAPY IN CARDIOVASCULAR PATIENTS
ten Cate H.	-	HYPERGLYCEMIA ACCELERATES ARTERIAL THROMBUS FORMATION AND ATTENUATES THE ANTITHROMBOTIC RESPONSE TO ENDOTOXIN IN MICE
	-	MARKERS OF FIBRINOLYSIS ARE INDEPENDENTLY RELATED TO FATTY LIVER AND HYPERTRIGLYCERIDEMIA IN FAMILIAL COMBINED HYPERLIPIDEMIA; EVIDENCE FOR INVOLVEMENT OF APOLIPOPROTEIN E
	-	ARGININE THERAPY TENDS TO REDUCE ENDOTHELIAL DAMAGE IN SEPSIS
	-	IN VIVO AVAILABILITY OF TWO RECOMBINANT FACTOR VIII PRODUCTS
	-	CIRCULATING MATRIX GLA PROTEIN: A POTENTIAL MARKER FOR VASCULAR COMPLICATIONS OF TYPE 2 DIABETES MELLITUS
ten Cate A.J.	-	LEVELS OF FACTOR VIII (FVIII), D-DIMER AND THROMBIN GENERATION (TG) IN PATIENTS AFTER ACUTE DEEP VEIN THROMBOSIS (DVT)
ten Cate H.	-	LEVELS OF FACTOR VIII (FVIII), D-DIMER AND THROMBIN GENERATION (TG) IN PATIENTS AFTER ACUTE DEEP VEIN THROMBOSIS (DVT)
	-	THROMBIN GENERATION IN CHRONIC MYELOPROLIFERATIVE DISORDERS (MPD)
	-	LOCALISATION OF COAGULATION PROTEINS WITHIN THE ARTERIAL VESSEL WALL IN RELATION TO PROGRESSION OF ATHEROSCLEROSIS
	-	VON WILLEBRAND FACTOR RELATED PARAMETERS IN SEVERE SEPSIS AND SEPTIC SHOCK
	-	COAGULATION FACTORS AND THE PROTEIN C SYSTEM AS DETERMINANTS OF THROMBIN GENERATION
	-	THROMBIN ACTIVATABLE FIBRINOLYSIS INHIBITOR (TAFI) THR325ILE AND FACTOR XII C46T POLYMORPHISMS IN ATHEROSCLEROTIC RENAL ARTERY STENOSIS
	-	ENDOGENOUS THROMBIN POTENTIAL, TISSUE FACTOR ANTIGEN LEVELS AND FIBRINOLYSIS IN SICKLE CELL PATIENTS WITH AND WITHOUT PULMONARY HYPERTENSION
	-	ACTIVE SITE INHIBITED FACTOR VIIA HAS A PROTECTIVE ROLE IN RENAL ISCHEMIA/REPERFUSION INJURY VIA ANTI-INFLAMMATORY MECHANISMS
	-	ACTIVE SITE INHIBITED FACTOR VIIA REDUCES MYOCARDIAL INFARCT SIZE AFTER ISCHEMIA/REPERFUSION INJURY IN MICE VIA TISSUE FACTOR/NFKAPPAB-MEDIATED MECHANISMS
	-	INHIBITION OF PROTEASE-ACTIVATED RECEPTOR (PAR)-4 PROTECTS FROM MULTI-ORGAN FAILURE IN A MURINE MODEL OF DISSEMINATED INTRAVASCULAR COAGULATION (DIC)
	-	THROMBIN GENERATION AND COAGULATION MARKERS IN PATIENTS WITH A FIRST ACUTE MYOCARDIAL INFARCTION
	-	THROMBOXANE B2 IN PATIENTS WITH A FIRST ACUTE MYOCARDIAL INFARCTION: THE INFLUENCE OF TREATMENT WITH ACETYLSALICYLIC ACID
	-	ACQUIRED RESISTANCE TO ACTIVATED PROTEIN C (APC) IN PATIENTS WITH ESSENTIAL THROMBOCYTHEMIA (ET)
	-	GENE EXPRESSION PROFILING IDENTIFIES C/EBP-DELTA AS A CANDIDATE REGULATOR OF ENDOTOXIN-INDUCED DISSEMINATED INTRAVASCULAR COAGULATION (DIC)
Ten Cate H.	-	THE NECESSITY OF CONTINUOUS INDIVIDUAL CALIBRATION IN CONTINUOUS FLUOROGENIC MEASUREMENT OF THE THROMBIN GENERATION CURVE
ten Cate H.	-	LUNG INFLAMMATION AND THROMBOGENIC RESPONSES IN A TIME COURSE STUDY OF WILD TYPE AND REPAIR DEFECTIVE CSB
	-	THE PROCOAGULANT EFFECTS OF PARTICULATE MATTER, A COMPONENT OF AIR POLUTION, IN THE LUNGS
	-	COMPARISON OF THROMBIN GENERATION AND FVIII LEVEL MEASUREMENTS IN HAEMOPHILIA PATIENTS AFTER RECOMBINANT FACTOR VIII TREATMENT
	-	ENHANCED THROMBUS FORMATION AFTER CHRONIC CHLAMYDIA PNEUMONIAE INFECTION IN A MURINE CAROTID ARTERY THROMBOSIS MODEL
ten Cate A.J.	-	THROMBIN GENERATION IN PATIENTS AFTER RECENT DEEP VEIN THROMBOSIS VERSUS HEALTHY CONTROLS
ten Cate H.	-	THROMBIN GENERATION IN PATIENTS AFTER RECENT DEEP VEIN THROMBOSIS VERSUS HEALTHY CONTROLS
	-	CHARACTERIZATION OF THE ROLE OF PLATELET ADHESION MOLECULES IN A MURINE MODEL OF PHOTOSENSITIZER-INDUCED STROKE
ten Kate M.K.	-	HIGH ABSOLUTE RISKS AND PREDICTORS OF VENOUS AND ARTERIAL THROMBOEMBOLIC EVENTS IN PATIENTS WITH NEPHROTIC SYNDROME
	-	PROS1 ANALYSIS IN 87 PEDIGREES WITH HEREDITARY PROTEIN S DEFICIENCY DEMONSTRATES STRIKING GENOTYPE-PHENOTYPE ASSOCIATIONS
	-	VALIDATION OF THE PROTEIN C/S RATIO TO IDENTIFY CARRIERS OF A PROTEIN S GENE MUTATION
ten Oever J.	-	MARKERS OF FIBRINOLYSIS ARE INDEPENDENTLY RELATED TO FATTY LIVER AND HYPERTRIGLYCERIDEMIA IN FAMILIAL COMBINED HYPERLIPIDEMIA; EVIDENCE FOR INVOLVEMENT OF APOLIPOPROTEIN E
Tenchini M.L.	-	ALTERNATIVE SPLICING AND NONSENSE-MEDIATED DECAY IN THE F5 GENE
	-	SIMULTANEOUS GENOTYPING OF FXI TYPE II AND TYPE III MUTATIONS BY MULTIPLEX REAL-TIME PCR IN HEALTHY ITALIANS AND IN FXI-DEFICIENT PATIENTS
Tenchini M.	-	CHARACTERIZATION OF THE F11 ALTERNATIVE SPLICING PATTERN: IDENTIFICATION OF A NOVEL COAGULATION FXI ISOFORM
	-	MISSENSE MUTATIONS IN THE COILED-COIL REGION OF FIBRINOGEN AALPHA CHAIN CAUSE FIBRINOGEN DEFICIENCY BY IMPAIRING DIMERIZATION OF TRIMERIC INTERMEDIATES
Tenchini M.L.	-	A NOVEL MECHANISM FOR CONGENITAL AFIBRINOGENEMIA BASED ON PSEUDOEXON ACTIVATION IN THE FIBRINOGEN GAMMA-CHAIN GENE
Tengborn L.	-	A WHOLE BLOOD CLOTTING METHOD MEASURING EX VIVO EFFECTS OF RFVIIA AND FVIII IN HAEMOPHILIA BLOOD
Tengvall P.	-	IMAGING OF BLOOD PLASMA COAGULATION AND ITS PROPAGATION AT SURFACES
Tenias J.	-	PROGNOSTIC FACTORS OF SHORT-TERM SURVIVAL IN PATIENTS WITH DEEP VEIN THROMBOSIS: FINDINGS FROM A PROSPECTIVE REGISTRY (RIETE)
	-	D-DIMER LEVELS CORRELATE WITH MORTALITY IN PATIENTS WITH ACUTE PULMONARY EMBOLISM: FINDINGS FROM THE RIETE REGISTRY
Tennant C.C.	-	THE ASSOCIATION OF DEPRESSION WITH PLATELET ACTIVATION: EVIDENCE FOR A TREATMENT EFFECT
Tennenbaum G.	-	ADAMTS-13 ACTIVITY, ANTIGEN AND INHIBITOR ANTIBODIES IN TTP PATIENTS A SINGLE CENTER EXPERIENCE
Tenorio-Lopez F.	-	EFFECT OF PROLAME, A 17 BETA-AMINOESTROGEN DERIVATIVE, ON CELL HEMOSTASIS
Tentsova I.	-	TRANSITION TO STANDARD HAEMOSTATIC THERAPY SCHEMES OF HEMOPHILIA IN RUSSIA (THE NATIONAL TREATMENT PROTOCOL FOR HEMOPHILIA PATIENTS)
Teo S.	-	CHANGES IN HAEMOSTATIC FACTORS DURING AND AFTER LIVER TRANSPLANTATION IN CHILDREN
Teplyakov A.I.	-	CORRECTION HAEMOSTASIOLOGIC AND RHEOLOGIC DISTURBANCES AT THE PATIENTS WITH ISCHEMIC HEART AND BRAIN DESIASES BY MEANS OF COMBINATION OF PHARMACOLOGICAL DRUGS AND EXTRACORPOREAL AUTOBLOOD-MAGNET-THERAPY
ter Avest P.C.	-	DISCORDANT ANTIBODY RESPONSE IN MONOZYGOTIC TWINS WITH SEVERE HAEMOPHILIA A
Terasawa F.	-	MARKEDLY IMPAIRED BUT SIGNIFICANT THROMBIN-CATALYZED FIBRIN POLYMERIZATION OBSERVED AT VARIANT FIBRINOGENS AT GAMMA364ASP RESIDUE IS ARISEN FROM B-KNOB AND B-HOLE BONDING
Ternisien C.	-	SUCCESSFUL TREATMENT OF HIGH TITRE FACTOR VIII (FVIII) INHIBITOR IN TWO PATIENTS WITH MILD AND MODERATE HAEMOPHILIA A WITH RITUXIMAB ALONE
Terpstra W.E.	-	COAGULATION PARAMETERS OF THE ISTH OVERT DIC SCORE: FIRST, THEIR DISTRIBUTION
Terrab A.	-	FACTOR V REMOVAL FROM BOVINE THROMBIN USED AS A TOPICAL HEMOSTAT IN SURGERY: IMPROVED PURITY THROUGH A NEW MANUFACTURING PROCESS
	-	VALIDATION OF AN IMPROVED PRION AND VIRUS ELIMINATION PROCESS IN THE MANUFACTURE OF BOVINE THROMBIN, A TOPICAL HEMOSTAT USED IN SURGERY
Terraube V.	-	CHARACTERIZATION OF THE INTERACTION BETWEEN VON WILLEBRAND FACTOR AND OSTEOPROTEGERIN
Terrisse A.	-	MICROPARTICLES FROM APOPTOTIC MONOCYTES (M-MPS) INDUCE TRANSIENT PLATELET RECRUITMENT AND TISSUE FACTOR (TF) EXPRESSION BY CULTURED HUMAN VASCULAR ENDOTHELIAL CELLS VIA A REDOX-SENSITIVE MECHANISM
Tersteegen A.	-	RIVAROXABAN AN ORAL, DIRECT FACTOR XA INHIBITOR BINDS RAPIDLY TO FACTOR XA
Teruya J.	-	FACTOR V AND THROMBIN INHIBITORS IN CHILDREN FOLLOWING BOVINE THROMBIN EXPOSURE
	-	PREVALENCE OF "ASPIRIN RESISTANCE" IN CHILDREN
Teske G.J.D.	-	UPAR IS AN IMPORTANT MODULATOR OF TUBULAR REPAIR AFTER RENAL ISCHEMIA REPERFUSION INJURY
Tesselaar M.E.T.	-	CIRCULATING MICROPARTICLE (MP)-ASSOCIATED TISSUE FACTOR (TF) ACTIVITY AND THROMBOSIS IN CANCER PATIENTS
Testa S.	-	EVALUATION OF A NEW D-DIMER METHOD
	-	LOW MOLECULAR WEIGHT HEPARIN (LMWH) BRIDGING THERAPY DURING SUBTHERAPEUTIC INR LEVELS IN VTE HIGH RISK PATIENTS
	-	ACCURACY AND COST EVALUATION OF A PORTABLE INR MONITOR
	-	PT INR: COMPARISON BETWEEN TWO DIFFERENT POINT OF CARE SYSTEMS
	-	PROTHROMBIN TIME: COMPARISON BETWEEN DIFFERENT REAGENTS
	-	EVALUATION OF A NEW INR PORTABLE MONITOR
	-	D-DIMER TESTING AND RECURRENT VENOUS THROMBOEMBOLISM AFTER UNPROVOKED PULMONARY EMBOLISM
Tetegan M.	-	FIBRIN MONOMER BY A QUANTITATIVE ASSAY IN PATIENTS WITH DISSEMINATED INTRAVASCULAR COAGULATION
Tevar A.	-	ADAMTS13 ACTIVITY AND AUTOANTIBODIES IN IDIOPATHIC TTP: RESULTS FROM THE SERF-TTP GROUP
	-	RISK FACTORS FOR THROMBOTIC THROMBOCYTOPENIC PURPURA: RESULTS OF THE SURVEILLANCE, EPIDEMIOLOGY AND RISK FACTORS FOR TTP (SERF-TTP) GROUP
Tezza F.	-	MYOCARDIAL INFARCTION AFTER OVARIAN STIMULATION FOR INFERTILITY MANAGEMENT
	-	THROMBOTIC THROMBOCYTOPENIC PURPURA IN PATIENT WITH LOW ADAMTS-13 ACTIVITY LEVELS BUT NO INHIBITORY AUTOANTIBODIES
Thalabard J.	-	ORAL OR VAGINAL ADMINISTRATION OF ETHINYL ESTRADIOL HAS A SIMILAR IMPACT ON LIVER PROTEINS AND COAGULATION MARKERS: RESULTS OF A RANDOMIZED, CROSS-OVER STUDY
Thaler C.J.	-	GENDER AND MENSTRUAL CYCLE INFLUENCE CIRCULATING MICROPARTICLES
Thames E.	-	THROMBOSIS AND HEMOSTASIS CENTERS PILOT SITES REGISTRY: MATERNAL THROMBOPHILIA
Thamm-Mücke B.	-	MONITORING AND THERAPY OF SEVERE ANTITHROMBIN DEFICIENCY IN PREGNANT WOMEN
	-	THROMBIN GENERATION AND THE TYPE OF ANTITHROMBIN DEFICIENCY
Than J.	-	MEASURES OF THROMBIN GENERATION DURING CARDIOPULMONARY BYPASS (CPB) IN
Than M.P.	-	MULTICENTER, PROSPECTIVE VALIDATION OF A DECISION RULE TO REDUCE EXCESS DIAGNOSTIC TESTING FOR PULMONARY EMBOLISM IN THE EMERGENCY DEPARTMENT
Thatte H.	-	DISCOVERY OF A POTENT, DIRECT THROMBIN INHIBITING APTAMER
the French Reference Center for Inherited Platelet Disorders	-	IDENTIFICATION OF 8 NOVEL MUTATIONS IN THE NON-MUSCLE MYOSIN HEAVY CHAIN 9 (MYH9) GENE IN 11 UNRELATED PATIENTS WITH MACROTHROMBOCYTOPENIA
Thedieck S.	-	ROLE OF ELEVATED ALPHA2-MACROGLOBULIN REVISITED: RESULTS OF A CASE-CONTROL STUDY IN CHILDREN WITH SYMPTOMATIC THROMBOEMBOLISM
	-	HAPLOTYPES OF THE PROTEIN Z GENE ASSOCIATED WITH SYMPTOMATIC THROMBOEMBOLISM IN CHILDREN
	-	INFLUENCE OF HERITABILITY AND HOUSEHOLD COMPONENTS ON LIPID CONCENTRATIONS AND CLOTTING FACTOR LEVELS IN 282 PEDIATRIC STROKE FAMILIES
Thelwell C.	-	TISSUE PLASMINOGEN ACTIVATOR AND PLASMINOGEN DOMAINS REGULATING THE POTENCY OF THERAPEUTIC THROMBOLYSIS
	-	THE KINETICS OF TPA ACTIVACTION AND INHIBTION BY PAI-1 IN FIBRIN
Theo S.	-	BLEEDING AND THROMBOTIC COMPLICATIONS OF LIVER TRANSPLANTATION IN CHILDREN
Theodoridis T.	-	HEPARIN INDUCED THROMBOCYTOPENIA: A LIFE THREATENING SYNDROME. THREE YEARS OF EXPERIENCE IN A LARGE GENERAL HOSPITAL
Theophilus B.D.	-	HETEROGENEOUS SEQUENCE CHANGES IN THE PROMOTER AND CODING SEQUENCE OF THE FACTOR VIII GENE IDENTIFIED IN 247 FAMILIES FROM THE UK
Thiam R.	-	ARE VASCULAR ENDOTHELIAL GROWTH FACTOR PLASMA LEVELS A PREDICTIVE MARKER OF SUNITINIB RESPONSE IN PATIENTS WITH METASTATIC RENAL CELL CARCINOMA?
Thiec F.	-	ROLE OF THE ALPHA-HELIX 163-170 IN FACTOR XA CATALYTIC ACTIVITY
Thiele T.	-	PROTEOMICS OF CELL-BASED THERAPEUTICS - PROFILING OF ALTERATIONS IN PLATELET PROTEINS DURING STORAGE OF PLATELET CONCENTRATES
Thielke R.	-	ACQUIRED HEMOPHILIA: ANALYSIS OF THE HEMOPHILIA AND THROMBOSIS RESEARCH SOCIETY (HTRS) REGISTRY
Thien T.	-	COMPRESSION BANDAGING IN THE ACUTE PHASE OF DEEP-VEIN THROMBOSIS IN RELATION TO THE POST-THROMBOTIC SYNDROME
Thijssen-Timmer D.C.	-	IN VIVO STUDIES OF NEWLY IDENTIFIED PLATELET-SPECIFIC GENES BY HUMAN PLATELET FORMATION IN NOD/SCID MICE AFTER TRANSPLANTATION OF CD34-POSITIVE CELLS
Thiruchelvam A.	-	IS TODAY'S THROMBOPHILIA PROFILE ADEQUATE IN IDENTIFYING A POSSIBLE CAUSE FOR RECURRENT FETAL LOSS IN WOMEN?
Thoennissen N.H.	-	CIRCULATING ANGIOPOIETIN-2 IS A STRONG PROGNOSTIC FACTOR IN ACUTE MYELOID LEUKEMIA
Thom K.	-	MONITORING HEPARIN LEVELS IN CHILDREN DURING CARDIAC CATHETERIZATION: COMPARISON OF ACTIVATED CLOTTING TIME, ACTIVATED PARTIAL PROTHROMBIN TIME, AND ANTI-XA ACTIVITY
Thom S.	-	CIRCULATING PLATELET-MONOCYTE COMPLEXES AS POTENTIAL BIOMARKERS OF THE OVERALL ATHEROSCLEROSIS LOAD IN MEN WITH AND WITHOUT KNOWN CORONARY ARTERY DISEASE
Thom J.	-	COMPARISON OF TWO ASSAYS FOR THE MEASUREMENT OF URINARY 11-DEHYRO THROMBOXANE B2
Thomas S.	-	RESISTANCE TO OAC ASSOCIATED TO A NEW POINT MUTATION IN VKORC1 GENE
Thomassen M.C.L.G.	-	MORE SEVERE HYPERCOAGULABLE STATE IN PROTHROMBIN G20210A CARRIERS THAN IN NON-CARRIERS WITH COMPARABLE PROTHROMBIN LEVELS
Thomassen S.	-	PROTEIN S-C4BP COMPLEX STIMULATES ACTIVATED PROTEIN C-MEDIATED INACTIVATION AT R306 BUT INHIBITS INACTIVATION AT R506 IN FACTOR VA
Thomassen M.L.G.D.	-	EFFECT OF ORAL CONTRACEPTIVES ON THROMBIN GENERATION MEASURED VIA CALIBRATED AUTOMATED THROMBOGRAPHY
Thompson P.	-	IMMUNOGLOBULIN ISOTYPES AND FUNCTIONAL ANTI-FVIII ANTIBODIES IN RESPONSE TO FVIII TREATMENT IN TWO STRAINS OF HEMOPHILIA A MICE
	-	IMMUNE TOLERANCE INDUCTION TO FVIII IN HEMOPHILIA A MICE USING SUBCUTANEOUSLY IMPLANTED FVIII GENE-MODIFIED ENDOTHELIAL PROGENITOR CELLS
Thompson A.R.	-	C2 DOMAIN T-CELL EPITOPES IN HEMOPHILIA A SUBJECTS WITH THE MUTATION A2201P
Thompson P.	-	ANTI-CD3 IN COMBINATION WITH NASAL FVIII-A2 DOMAIN DECREASES FVIII INHIBITORS
Thompson J.	-	EVALUATION OF THE POINT OF CARE MICRO-COAGULATION TESTS IN PEDIATRICS
Thompson P.	-	SAFE AND LONG-TERM EXPRESSION OF FVIII FOLLOWING SUBCUTANEOUS IMPLANTATION OF GENETICALLY-MODIFIED ENDOTHELIAL PROGENITORS IN HEMOPHILIA A MICE
Thomsen M.	-	LATE BREAKING CLINICAL TRIALS- BIOPHYSICAL INVESTIGATION OF A CONFORMATIONAL DISEASE: ANTITHROMBIN III AALBORG
Thon J.N.	-	APPLICATION OF PROTEOMICS TO THE IDENTIFICATION OF PROTEINS ASSOCIATED WITH THE PLATELET STORAGE LESION AND THEIR TRANSLATION
Thongsad J.	-	NORMALIZED PHOSPHATIDYLSERINE EXPRESSION ON RED BLOOD CELLS IN CHILDREN WITH SEVERE THALASSEMIA DISEASE AFTER STEM CELL TRANSPLANTATION
Thorel D.	-	INHERITED FVII DEFICIENCY MOLECULAR DIAGNOSIS: SCREENING FOR LARGE REARRANGEMENTS IN THE FVII GENE
Thornburg C.	-	THROMBOSIS AND HEMOSTASIS CENTERS PILOT SITES REGISTRY: MATERNAL THROMBOPHILIA
	-	THROMBOSIS AND HEMOSTASIS CENTERS PILOT SITES REGISTRY: THROMBOPHILIA SCREENING IN CHILDREN
Thornton S.N.	-	AGE-DEPENDENT INCREASED ARTERIAL STIFFNESS IS ASSOCIATED WITH COMPOSITE CHANGES IN PRO- AND ANTI-COAGULANT REACTIONS IN SUBCLINICAL ATHEROSCLEROSIS
Thorslund S.	-	A NOVEL HIGHLY PROMISING POINT-OF-CARE METHOD FOR HIV MONITORING
Thouvenin S.	-	HIGH DOSES OF RECOMBINANT ACTIVATED FACTOR VII (RFVIIA) IN A HEMOPHILIA A PATIENT WITH INHIBITOR
Thürlemann C.	-	MONITORING THROMBIN GENERATION IN WHOLE BLOOD BY ELECTROCHEMISTRY - A NEW APPROACH FOR SCREENING THROMBOPHILIC AND HEMOPHILIC RISKS
Thurston S.	-	RECOMBINANT ACTIVATED FACTOR VII VS. ACTIVATED PROTHROMBIN COMPLEX CONCENTRATE AS ON-DEMAND TREATMENT OF JOINT BLEEDS IN HEMOPHILIACS WITH INHIBITORS: A SYSTEMATIC LITERATURE REVIEW
Thys C.	-	SEVERE GASTRO-INTESTINAL BLEEDING AND THROMBOCYTOPENIA DUE TO AN ANTI-GATA AUTOANTIBODY
	-	DEVELOPMENT OF MEGAKARYOCYTE-SPECIFIC LENTIVIRAL VECTORS FOR GENE THERAPY OF PLATELET DISORDERS
	-	HYPERREACTIVE PLATELETS IN PATIENTS WITH GS DEFICIENCY
Tian X.	-	RISTOCETIN-INDUCED AGGREGATION OF HUMAN GPIBALPHA TRANSGENIC MICE IS INHIBITED BY ANTI-HUMAN GPIBALPHA ANTIBODIES IN THE PRESENCE OF HUMAN PLASMA
Tiberio G.	-	D-DIMER LEVELS CORRELATE WITH MORTALITY IN PATIENTS WITH ACUTE PULMONARY EMBOLISM: FINDINGS FROM THE RIETE REGISTRY
	-	PROGNOSTIC FACTORS OF SHORT-TERM SURVIVAL IN PATIENTS WITH DEEP VEIN THROMBOSIS: FINDINGS FROM A PROSPECTIVE REGISTRY (RIETE)
Tick L.W.	-	FURTHER VALIDATION AND SIMPLIFICATION OF THE WELLS CLINICAL DECISION RULE IN PULMONARY EMBOLISM
	-	HIGH D-DIMER LEVEL INCREASES THE LIKELIHOOD OF PULMONARY EMBOLISM IN A HIGH-RISK POPULATION
	-	CLINICALLY SUSPECTED ACUTE RECURRENT PULMONARY EMBOLISM: A DIAGNOSTIC CHALLENGE
Tiede A.	-	AN EX VIVO PERFUSION MODEL TO STUDY THE TREATMENT OF THROMBOTIC MICROANGIOPATHY DURING PIG-TO-HUMAN XENOGENIC KIDNEY TRANSPLANTATION
Tiedt R.	-	MEGAKARYOCYTE-RESTRICTED MYH9 INACTIVATION DRAMATICALLY AFFECTS HAEMOSTASIS WHILE PRESERVING PLATELET AGGREGATION AND SECRETION RESPONSES
Tieghi A.	-	A SURVEY ON POST-SURGERY OUTCOMES IN PATIENTS WITH ESSENTIAL THROMBOCYTHEMIA AND POLYCYTHEMIA VERA IN A RETROSPECTIVE COHORT
Tielens A.G.M.	-	THE OUTER-SURFACES OF SCHISTOSOMA MANSONI DURING THE LIFE-CYCLE DEMONSTRATE DIFFERENTIAL PROPERTIES TOWARDS PLATELET ADHESION
Tiel-van Buul M.	-	THE VALUE OF PET- SCANNING IN THE DETECTION OF OCCULT CANCER IN PATIENTS WITH VENOUS THROMBOEMBOLISM
Tigyi G.	-	THE PLAQUE LIPID LYSOPHOSPHATIDIC ACID STIMULATES PLATELETS NOT THROUGH THE LPA1, LPA2 AND LPA3 RECEPTOR
Tijssen J.G.	-	RETRANSFUSION OF PERICARDIAL BLOOD DOES NOT TRIGGER SYSTEMIC COAGULATION DURING CARDIOPULMONARY BYPASS
Tijssen M.R.	-	IN VIVO STUDIES OF NEWLY IDENTIFIED PLATELET-SPECIFIC GENES BY HUMAN PLATELET FORMATION IN NOD/SCID MICE AFTER TRANSPLANTATION OF CD34-POSITIVE CELLS
Tillmanns H.	-	THE DISTRIBUTION OF FACTOR SEVEN ACTIVATING PROTEASE (FSAP) IN CAROTID AND CORONARY ATHEROSCLEROTIC PLAQUES IN SUBJECTS GENOTYPED FOR THE MARBURG I POLYMORPHISM
Tincani A.	-	ANTIPHOSPHOLIPID ANTIBODIES AND EX-VIVO ENDOTHELIAL PERTURBATION
Tinel H.	-	RECOMBINANT FACTOR VIIA PARTIALLY REVERSES THE ANTICOAGULANT EFFECT OF HIGH-DOSE RIVAROXABAN A NOVEL, ORAL, DIRECT FACTOR XA INHIBITOR IN RATS
Tinot T.	-	SERIOUS BLEEDS IN HAEMOPHILIAC A CHILDREN AND CONTINUOUS INFUSION (CI)
Tio R.A.	-	PLATELET RECEPTOR P2Y12 HAPLOTYPES PREDICT RESTENOSIS AFTER PERCUTANEOUS CORONARY INTERVENTIONS
	-	THE FACTOR VII ACTIVATING PROTEASE (FSAP) POLYMORPHISM (G534E) IS ASSOCIATED WITH A DECREASED RISK FOR RESTENOSIS AFTER PERCUTANEOUS CORONARY INTERVENTION
Tirado I.	-	IGM ANTI PROTEIN S ANTIBODIES AS A RISK FACTOR OF VENOUS THROMBOSIS
	-	MATRIX METALLOPROTEINASE 9 (MMP-9), THROMBIN-ANTITHROMBIN COMPLEXES (TAT) AND THE FACTOR XIII VAL34LEU POLYMORPHISM IN PATIENTS WITH SPONTANEOUS ACUTE INTRACRANIAL HEMORRHAGE
	-	CONTRIBUTION OF C46T MUTATION IN F12 GENE TO THROMBOTIC RISK IN THROMBOPHILIC FAMILIES WITH FACTOR V LEIDEN MUTATION
Tiran B.	-	ENDOGENOUS THROMBIN POTENTIAL IN 3183 PARTICIPANTS OF THE LUDWIGSHAFEN RISK AND CARDIOVASCULAR HEALTH (LURIC) STUDY
Tiret I.	-	RISK FACTOR FOR ORAL ANTICOAGULANT TREATMENT OVERDOSE: A CASE CONTROL STUDY IN AN EMERGENCY UNIT
Tiscia G.L.	-	COMMON GENE MUTATIONS AND VENOUS THROMBOEMBOLISM: DISTINCT ROLES IN DIFFERENT CLINICAL SETTINGS
Tiscia G.	-	EFFICACY OF ENOXAPARIN IN PREVENTING ADVERSE FETO-MATERNAL OUTCOMES IN CARRIERS OF ANTICOAGULANTS DEFICIENCY
Tiscione V.	-	RANDOMISED, OPEN, PROSPECTIVE, MULTICENTER PILOT STUDY TO EVALUATE THE EFFICACY AND SAFETY OF ACTIVATED RECOMBINANT FACTOR VIIA (NOVOSEVEN) IN ACUTE INTRACEREBRAL HAEMORRHAGE IN PATIENTS TREATED WITH ORAL ANTICOAGULANT OR ANTIPLATELET AGENTS
Titaeva E.	-	D-DIMER IN PATIENTS WITH CLINICAL SIGNS OF ATHEROTHROMBOSIS IN DIFFERENT VASCULAR BEDS
Tjandra H.	-	SITE-SPECIFIC PEGYLATION OF RFVIII RESULTS IN PROLONGED IN VIVO EFFICACY
	-	EVALUATION OF PEG-FVIII MOLECULES WITH PROLONGED HALF-LIVES IN A MURINE FVIII-DEPENDENT BLEEDING MODEL
Tjandra J.	-	MUTATIONS AT THE LOW-DENSITY LIPOPROTEIN RECEPTOR-RELATED PROTEIN (LRP) BINDING SITE OF THE FVIII A2 DOMAIN DID NOT REDUCE LRP BINDING OR INCREASE HALF-LIFE OF NON-ACTIVATED FVIII
Tjwa M.	-	THROMBOSPONDIN1 GENE DEFICIENCY ATTENUATES ATHEROSCLEROTIC PLAQUE BURDEN BUT ACCENTUATES INFLAMMATORY CELL PLAQUE CONTENT IN APOE-DEFICIENT MICE
	-	THROMBOSPONDIN1 GENE DEFICIENCY MODULATES VASCULAR MEDIAL SMOOTH MUSCLE CELL ACTIVATION AND NEOINTIMA FORMATION
Tobu M.	-	COMPARATIVE STUDY ON THE ANTICOAGULANT EFFECTS OF UNFRACTIONATED AND LOW MOLECULAR WEIGHT HEPARINS, LOWER LOW MOLECULAR WEIGHT HEPARINS AND PENTASACCAHRIDE AS MEASURED BY WHOLE BLOOD ACT, ANTI-XA AND A NEWLY DEVELOPED PROTHROMBINASE INDUCED CLOTTING TIME
Todoli J.	-	FIBRINOLYTIC INHIBITORS LEVELS AND POLYMORPHISMS IN BEHCET DISEASE. THEIR RELATIONSHIP WITH VENOUS THROMBOSIS
Toennes S.W.	-	PHARMACOGENETICS OF ORAL ANTICOAGULATION - VKORC1-HAPLOTYPES DETERMINE THE INTER-INDIVIDUAL VARIABILITY
	-	DETERMINATION OF CLOPIDOGREL MAIN METABOLITE IN PLASMA USEFUL TOOL FOR THERAPY MONITORING ?
Tofler G.H.	-	THE ASSOCIATION OF DEPRESSION WITH PLATELET ACTIVATION: EVIDENCE FOR A TREATMENT EFFECT
Tognin G.	-	RELATION BETWEEN ENDOTHELIAL AND PLATELETS MICROPARTICLES AND VENOUS THROMBOEMBOLISM: A CASE-CONTROL STUDY
	-	DECREASE FACTOR VIIA/ANTITHROMBIN COMPLEXES IN 31 SUBJECTS BELONGING TO 7 FAMILIES WITH FVII DEFICIENCY
	-	INFLUENCE OF HAEMATOCRIT ON ROTEM PARAMETERS
	-	DECREASE FACTOR VIIA/ANTITHROMBIN COMPLEXES IN PATIENTS WITH VENOUS THROMBOEMBOLISM: A NEW INSIGHT IN THE PATHOGENETIC MECHANISM
	-	STUDY OF PLATELETS FACTOR V UPTAKE IN HUMAN MEGAKARYOCYTE CULTURES FROM PATIENTS WITH PARAHEMOPHILIA
	-	RECOMBINANT HUMAN ACTIVATED PROTEIN C (RHAPC) IN PIG-TO-PRIMATE XENOTRANSPLANTATION
Tognoni G.	-	PERSISTENT PLATELET ACTIVATION IN PATIENTS WITH TYPE 2 DIABETES TREATED WITH LOW DOSES OF ASPIRIN
Toh C.H.	-	THE BIPHASIC APTT WAVEFORM AS A BIOMARKER FOR TARGETING TREATMENT WITH RECOMBINANT ACTIVATED PROTEIN C (APC)
Toh C.	-	INACTIVATION OF ALPHA-1-PROTEASE INHIBITOR DURING CLINICAL SEPSIS-INDUCED DISSEMINATED INTRAVASCULAR COAGULATION IS NOT CONSISTENT WITH INHIBITOR POLYMERIZATION
	-	CYTOPROTECTION AND ANTICOAGULATION BY ACTIVATED PROTEIN C ON CIRCULATING MICROPARTICLE-ASSOCIATED ENDOTHELIAL PROTEIN C RECEPTOR
Tokay B.	-	ORAL OR VAGINAL ADMINISTRATION OF ETHINYL ESTRADIOL HAS A SIMILAR IMPACT ON LIVER PROTEINS AND COAGULATION MARKERS: RESULTS OF A RANDOMIZED, CROSS-OVER STUDY
Toku M.	-	IMPAIRED BINDING OF THROMBIN TO THROMBOMODULIN IS ASSOCIATED WITH RISK OF DEEP VEIN THROMBOSIS
	-	IMPAIRED BINDING OF THROMBIN TO THROMBOMODULIN IS ASSOCIATED WITH RISK OF DEEP VEIN THROMBOSIS
Tokuc B.	-	LONGITUDINAL OBSERVATION OF TAFI LEVELS ALONG NORMAL PREGNANCY AND PUERPERIUM: RELATIONSHIP BETWEEN TAFI AND OTHER MARKERS OF FIBRINOLYSIS
Toll D.B.	-	A DIAGNOSTIC TOOL TO SAFELY EXCLUDE DVT IN HIGH RISK GROUPS
	-	A DIAGNOSTIC TOOL TO SAFELY EXCLUDE DVT IN PRIMARY CARE: A VALIDATION STUDY
Tollefsen D.M.	-	ACCELERATED ATHEROGENESIS AND NEOINTIMA FORMATION IN HEPARIN COFACTOR II DEFICIENT MICE
Tollner A.	-	BIOLOGICAL ACTIVITY OF PEGYLATED FACTOR VIII
Toltl L.J.	-	NOVEL REGULATORY FUNCTIONS OF ACTIVATED PROTEIN C: UPREGULATION OF INTERLEUKIN-10 AND INHIBITION OF TISSUE FACTOR IN BLOOD MONOCYTES
Tom B.D.	-	THE EFFECT OF APHERESIS ON DONORS' PLATELETS
	-	ANALYSING PLATELET FUNCTION FOR FUNCTIONAL GENOMIC STUDIES
Tomaiuolo M.	-	A RAPID METHOD FOR THE QUANTIFICATION OF THE ENANTIOMERS OF WARFARIN, PHENPROCOUMON AND ACENOCOUMAROL BY TWO DIMENSIONAL-ENANTIOSELECTIVE LIQUID CHROMATOGRAPHY/ELECTROSPRAY TANDEM MASS SPECTROMETRY
Tomalski M.D.	-	RECOMBINANT HUMAN PLASMIN PRODUCED IN LEMNA MINOR
Tomasi C.	-	OUTCOME OF PATIENTS WITH SUSPECTED SYMPTOMATIC DEEP-VEIN THROMBOSIS (DVT) AND A NORMAL ULTRASOUND-BASED INITIAL DIAGNOSTIC WORKUP. A PROSPECTIVE STUDY
Tomer A.	-	ANTIPHOSPHOLIPID ANTIBODY SYNDROME (APS): THE ANNEXIN V COMPETITION ASSAY AS A DIAGNOSTIC TOOL
Tomic B.	-	THE 3'UTR PROTHROMBIN GENE POLYMORPHISMS IN THROMBOHILIC SERBIAN POPULATION
Tomin D.S.	-	EFFEKT OF PARAPROTEINS ON PLATELET AGGREGATION
Tomiyama Y.	-	SEMAPHORIN 3A ANTAGONIZES AGONIST-INDUCED PI3 KINASE PATHWAY IN PLATELETS
Tomlinson M.G.	-	CD148 IS AN ESSENTIAL POSITIVE REGULATOR OF ITAM AND INTEGRIN RECEPTOR SIGNALLING IN PLATELETS
	-	THE PLATELET ACTIVATION C-TYPE LECTIN RECEPTOR CLEC-2 SIGNALS VIA A NOVEL YXXL DEPENDENT SIGNALLING CASCADE DISTINCT FROM THAT OF ITAM RECEPTORS
	-	NOVEL PLATELET MEMBRANE RECEPTORS AND SIGNALLING PROTEINS
	-	COLLAGEN PROMOTES SUSTAINED GPVI SIGNALING IN PLATELETS AND CELL LINES
	-	PLATELET ITIM PROTEINS INHIBIT BASAL SIGNALLING BY YXXL-CONTAINING PLATELET ACTIVATION RECEPTORS
	-	CD148 IS A POSITIVE REGULATOR OF PLCGAMMA2 ACTIVATION BY GPVI
Tomoike H.	-	AGE- AND GENDER-RELATED DIFFERENCES OF PLASMA PROTHROMBIN ACTIVITY LEVELS
	-	GENETIC POLYMORPHISMS OF ENDOTHELIN CONVERTING ENZYME-1 GENE ASSOCIATED WITH HYPERTENSION IN A JAPANESE POPULATION AND A NOVEL MISSENSE MUTATION IN PREPROENDOTHELIN-1 IN A JAPANESE HYPERTENSIVE
Tomokiyo K.	-	Pharmacokinetics of a mixture of FVIIa and FX in rats
Tomsic M.	-	ENDOTHELIAL FUNCTION IN PATIENTS WITH ANTIPHOSPHOLIPID SYNDROME AND HISTORY OF VENOUS THROMBOSIS
Tona F.	-	SHORT TERM BETAINE ADMINISTRATION IN PATIENTS WITH COLLAGEN VASCULAR DISEASE-MEDIATED SEVERE PULMONARY ARTERIAL HYPERTENSION
	-	MARKERS OF ENDOTHELIAL CELL ACTIVITY BEFORE AND AFTER BOSENTAN THERAPY IN PATIENTS WITH SEVERE PULMONARY HYPERTENSION DUE TO CONNECTIVE TISSUE DISEASE
Tonello M.	-	DETECTION OF ANTI-BETA2-GLYCOPROTEIN I ANTIBODIES: THE INFLUENCE OF DIFFERENT ANTIGEN PREPARATIONS
	-	THE MANAGEMENT OF HIGH RISK PREGNANT PATIENTS WITH PRIMARY ANTIPHOSPHOLIPID SYNDROME
Toni D.	-	RANDOMISED, OPEN, PROSPECTIVE, MULTICENTER PILOT STUDY TO EVALUATE THE EFFICACY AND SAFETY OF ACTIVATED RECOMBINANT FACTOR VIIA (NOVOSEVEN) IN ACUTE INTRACEREBRAL HAEMORRHAGE IN PATIENTS TREATED WITH ORAL ANTICOAGULANT OR ANTIPLATELET AGENTS
Tonismagi K.	-	PLATELET AGGREGATION INHIBITING COMPONENTS FROM VIPERA LEBETINA SNAKE VENOM
Toogeh G.R.	-	EVALUATION OF THE USE OF RECOMBINANT FVIIA, NOVOSEVEN IN 28 GLANZMANN'S THROMBASTHENIA PATIENTS
Tootian S.	-	THE PROTECTIVE EFFECT OF FXIII VAL34LEU POLYMORPHISM AGAINST VENOUS THROMBOSIS IN IRANIAN PATIENTS
Topalidou M.	-	SECONDARY THROMBOPHYLAXIS USING ANTIPLATELET AGENTS AND LONG TERM MONITORING AFTER 1ST UNPROVOKED EPISODE OF VENOUS THROMBOEMBOLISM
Topf H.	-	PERCUTANEOUS CATHETER EXTRACTION OF A RUPTURED PORT-A-CATH IN A SMALL CHILD WITH HAEMOPHILIA A AND F VIII INHIBITOR USING CONTINUOUS INFUSION OF RFVIIA
	-	INFLUENCE OF STORAGE CONDITIONS ON THROMBIN GENERATION IN PLATELET POOR PLASMA
Topol E.J.	-	P2RY12 RECEPTOR POLYMORPHISMS (SNPS) IN PATIENTS WITH A HISTORY OF MYOCARDIAL INFARCTION
Topolyev I.R.	-	CLINICAL USE OF TEST OF LYMPHOCYTE-PLATELET ADHESION
Torchet M.	-	IMMUNE TOLERANCE IN AN ADULT AFTER A LONG TERM HISTORY OF I,HIBITOR
Torchin D.	-	EFFECT OF TWO DOSES OF ORAL OESTROGEN REPLACEMENT THERAPY ON THE PROTEIN C SYSTEM IN POSTMENOPAUSAL WOMEN. A RANDOMISED DOUBLE BLIND PLACEBO-CONTROLLED STUDY
Toren A.	-	ISRAELI PEDIATRIC ONCOLOGY REGISTRY ON CENTRAL VENOUS LINE RELATED COMPLICATIONS
Torggler Filho F.	-	EFFECT OF THE IMPLEMENTATION OF A VENOUS THROMBOEMBOLISM PROPHYLAXIS GUIDELINE IN THE MANAGEMENT OF SURGICAL AND ORTHOPEDIC PATIENTS IN A PRIVATE TERTIARY HOSPITAL
Tormene D.	-	THE G20210A PROTHROMBIN VARIANT (PT-G20210A) AND THE RISK OF THROMBOEMBOLISM AND FOETAL LOSS IN PREGNANT WOMEN
	-	D-DIMER AS AN ADJUNCT TO COMPRESSION ULTRASONOGRAPHY IN PATIENTS WITH SUSPECTED RECURRENT IPSILATERAL DEEP VEIN THROMBOSIS. A PROSPECTIVE COHORT STUDY
	-	THE RISK OF PREGNANCY-RELATED VENOUS THROMBOEMBOLISM IN DOUBLE CARRIERS OF FACTOR V LEIDEN AND PROTHROMBIN G20210A
	-	THROMBOPHILIA AS A PREDICTOR OF RESIDUAL VEIN THROMBOSIS. A PROSPECTIVE COHORT STUDY
	-	THE RISK OF RECURRENT VENOUS THROMBOEMBOLISM AFTER DISCONTINUING ANTICOAGULATION IN PATIENTS WITH ACUTE PROXIMAL DEEP VEIN THROMBOSIS OR PULMONARY EMBOLISM. A PROSPECTIVE COHORT STUDY
	-	FACTOR V LEIDEN IS ASSOCIATED WITH MORE DISTAL LOCATION OF DEEP VEIN THROMBOSIS OF THE LEG
	-	MORE SEVERE HYPERCOAGULABLE STATE IN PROTHROMBIN G20210A CARRIERS THAN IN NON-CARRIERS WITH COMPARABLE PROTHROMBIN LEVELS
	-	INCREASED ENDOGENOUS THROMBIN POTENTIAL (ETP) IN PATIENTS OF FAMILIES WITH INHERITED AT DEFECTS
Tornai I.	-	VWF FUNCTIONS, ADAMTS-13 ACTIVITY AND ANTIGEN LEVELS IN PATIENTS WITH LIVER CIRRHOSIS
Tornvall P.	-	EFFECT OF CLOPIDOGREL TREATMENT ON STRESS-INDUCED PLATELET ACTIVATION AND MYOCARDIAL ISCHEMIA IN ASPIRIN-TREATED PATIENTS WITH STABLE CORONARY ARTERY DISEASE
Torrens N.	-	AN EVALUATION OF A PHARMACY INPATIENT ANTICOAGULATION SERVICE IN GENERAL & EMERGENCY MEDICINE
Torres O.	-	IMPAIRED THROMBOPOIESIS AFTER STEM CELL INFECTION WITH JUNIN VIRUS
	-	TREATMENT WITH RECOMBINANT ACTIVATED FVII DECREASES FVIII INHIBITOR TITLE
	-	ROLE OF PPAR-GAMMA ACTIVATION IN MEGAKARYOCYTOPOIESIS
	-	DIFFERENTIATION OF CD34+ CELLS MEDIATED BY THROMBOPOIETIN AND MONOCYTES/MACROPHAGES
Torres I.	-	BISBUDIAME, AN ESTROGEN DERIVATIVE WITH AN ANTITHROMBOTIC EFFECT
	-	NATIONAL STUDY OF INHIBITOR KINETICS AND TREATMENT RESPONSE IN HEMOPHILIA A AND B MEXICAN PATIENTS
Torricelli F.	-	ROLE OF INFLAMMATION IN MODULATING GRAFT TOLERANCE INDUCED BY MESENCHIMAL STEM CELLS
Torti M.	-	MODULATION OF PLATELET FUNCTION BY THE ENDOCANNABINOID 2-ARACHIDONOYLGLYCEROL
	-	VON WILLEBRAND FACTOR AND GPIB-IX-V REGULATE PROPLATELETS FORMATION BY HUMAN MEGAKARYOCYTES
	-	EVIDENCE FOR THROMBIN-INDUCED PLATELET ACTIVATION INDEPENDENT OF PAR1, PAR4, AND GPIB-IX-V
Tosato F.	-	SUBMASSIVE PULMONARY EMBOLISM: ROLE OF THROMBOLITIC THERAPY
Tosertto A.	-	THE VON WILLEBRAND FACTOR (VWF) AND FACTOR VIII ACTIVITIES VERSUS VWF ANTIGEN RATIOS IN PATIENTS WITH VON WILLEBRAND DISEASE TYPE 1: RESULTS FROM THE EUROPEAN MULTICENTER MCMDM-1VWD STUDY
Tosetto A.	-	ANTITHROMBIN DEFICIENCY IN THE GENERAL POPULATION IS RARELY DUE TO AT GENE MUTATIONS, WHICH ARE MAINLY REPRESENTED BY ALA384SER MUTATION
	-	RESIDUAL VENOUS OBSTRUCTION AND D-DIMER AS RISK FACTORS FOR RECURRENCE AFTER ANTICOAGULATION WITHDRAWAL FOR A FIRST IDIOPATHIC DEEP VEIN THROMBOSIS IN THE PROLONG STUDY
	-	HOW TO ESTIMATE BLEEDING RISK IN MILD BLEEDING DISORDERS
	-	THE G20210A PROTHROMBIN VARIANT (PT-G20210A) AND THE RISK OF THROMBOEMBOLISM AND FOETAL LOSS IN PREGNANT WOMEN
	-	DIFFERENT CUT-OFF VALUES OF THREE D-DIMER (DD) TESTS TO ESTABLISH DURATION OF ORAL ANTICOAGULATION TREATMENT (OAT) AFTER A VENOUS THROMBOEMBOLISM (VTE)
	-	A BAYESIAN APPROACH TO THE DIAGNOSIS OF TYPE 1 VON WILLEBRAND DISEASE
	-	HETEROGENEITY OF PHENOTYPES IN PATIENTS WITH VON WILLEBRAND DISEASE ASSOCIATED WITH NULL MUTATIONS: AN OBSERVATION IN FAMILIES WITH THREE NOVEL MUTATIONS
	-	TEN NOVEL MUTATIONS IN FXI GENE
	-	THE RISK OF PREGNANCY-RELATED VENOUS THROMBOEMBOLISM IN DOUBLE CARRIERS OF FACTOR V LEIDEN AND PROTHROMBIN G20210A
	-	BLEEDING SCORE IS INCREASED IN AFFECTED RELATIVES WITH TYPE 1 VON WILLEBRAND DISEASE AND ABNORMAL MULTIMERIC PATTERN IDENTIFIED IN THE EU MCMDM-1 VWD STUDY
	-	A SURVEY ON POST-SURGERY OUTCOMES IN PATIENTS WITH ESSENTIAL THROMBOCYTHEMIA AND POLYCYTHEMIA VERA IN A RETROSPECTIVE COHORT
	-	D-DIMER TESTING AND RECURRENT VENOUS THROMBOEMBOLISM AFTER UNPROVOKED PULMONARY EMBOLISM
Totani L.	-	PERSISTENT PLATELET ACTIVATION IN PATIENTS WITH TYPE 2 DIABETES TREATED WITH LOW DOSES OF ASPIRIN
	-	ANTI-INFLAMMATORY EFFECS OF CLOPIDOGREL IN THE MOUSE
	-	PHOSPHODIESTERASE-TYPE IV REGULATES PMN/PLATELET INTERACTION IN VITRO AND PMN ACCUMULATION AT THE SITE OF VASCULAR INJURY IN VIVO
Toth O.	-	THE EFFECT OF ADP RECEPTOR ANTAGONISTS AND ASPIRIN ON WHOLE BLOOD PLATELET AGGREGATION MEASURED BY MULTIPLE ELECTRODE AGGREGOMETRY
Toth J.	-	POLYCYTHAEMIA VERA, ANTIPHOSPHOLPID ANTIBODIES AND ACQUIRED PLATELET FUNCTION ABNORMALITIES
Toth B.	-	GENDER AND MENSTRUAL CYCLE INFLUENCE CIRCULATING MICROPARTICLES
Tóth J.	-	A PILOT STUDY WITH AUTOLOGOUS BONE MARROW-DERIVED STEM CELL TRANSPLANTATION (ABSCT) IN PATIENTS WITH SEVERE PERIPHERAL ARTERIAL DISORDER (SPAD)
Tóth E.	-	TRANSIENT ACTIVATION OF BLOOD COAGULATION FACTOR XIII BY POLYMORPHONUCLEAR GRANULOCYTE ELASTASE
Tóth O.	-	EFFECT OF ANTI-PLATELET DRUGS ON PLATELET AGGREGATION AND THROMBUS FORMATION INDUCED BY HUMAN ATHEROSCLEROTIC PLAQUES
Toth-Zsamboki E.	-	STUDY OF IN VIVO AND IN VITRO ADMINISTERED ASPIRIN'S ANTIPLATELET EFFECT: POSSIBLE MECHANISMS OF ASPIRIN RESISTANCE
Tóth-Zsámboki E.	-	HIGH NOREPINEPHRINE LEVEL IS ASSOCIATED WITH SIGNIFICANT PLATELET HYPERREACTIVITY DEMONSTRATED BY INCREASED PLATELET P-SELECTIN POSITIVITY, ADENOSIN DIPHOSPHATE AND COLLAGEN INDUCED AGGREGATIONS IN STABLE CORONARY HEART DISEASE PATIENTS ON DUAL ANTIPLATEL
Toth-Zsamboki E.	-	ASSESSMENT OF PLATELET P2Y1 FUNCTION IN CLOPIDOGREL-TREATED ISCHEMIC HEART DISEASE PATIENTS
	-	CLOPIDOGREL TREATMENT SIGNIFICANTLY DECREASES CIRCULATING ENDOTHELIAL CELL COUNT IN PATIENTS WITH STABLE ANGINA
Toton J.	-	CONTRIBUTION OF ALPHA-FIBRINOGEN A312 ALLELE TO DECREASED THROMBIN GENERATION IN PATIENTS SCHEDULED FOR CORONARY ARTERY BYPASS GRAFTING SURGERY
Totta P.	-	THROMBIN-MEDIATED IMPAIRMENT OF FGF-2 ACTIVITY
Touat Z.	-	INCREASED PLASMA MARKERS OF PLATELET AND PROTHROMBIN ACTIVATION IN PATIENTS WITH THORACIC ASCENDING AORTIC ANEURYSM
Touchrift C.C.T.	-	HEMOSTASIS AND PREGNANCY: PRELIMINARY STUDY
Touchrift C.	-	NORMAL VALUES IN PERINATAL AND PEDIATRIC HEMOSTASIS IN ALGIERS
Touitou C.	-	MISUSE OF THE D-DIMER TEST IN HOSPITALISED PATIENTS
Toulon P.A.	-	ORIENTIA TSUTSUGAMUSHI INFECTION (SCRUB TYPHUS) IS ASSOCIATED WITH AN INFRACLINICAL ACTIVATION OF THE COAGULATION SYSTEM BUT NOT WITH AN ACTIVATION OF ENDOTHELIAL CELLS
Toulon P.	-	THROMBOPATH KIT CORRELATES BETTER WITH FREE PROTEIN S TO PROTHROMBIN RATIO AND FUNCTIONAL PS THAN WITH FREE PS
Tournoys A.	-	ROTEM THROMBOELASTOMETRY IN OBSTETRIC: NEAR PATIENT-TEST AS AN EARLY PREDICTOR OF POST-PARTUM HEMORRHAGE (PPH)
	-	ANTITHROMBIN REDUCES COAGULATION AND INFLAMMATION IN A PIG MODEL OF ISLET TRANSPLANTATION
Toyoda Y.	-	ALLELIC FREQUENCY AND MINOR VARIATIONS OF THE FACTOR V R2 HAPLOTYPE IN JAPANESE POPULATION
Toyooka K.	-	PREVALENCE OF DEEP VENOUS THROMBOSIS OR PULMONARY EMBOLISM (DVT/PE) IN PSYCHIATRY PATIENTS
Trabant A.	-	AN IN VIVO RISK/BENEFIT COMPARISON OF THE EFFECTS OF RIVAROXABAN AN ORAL, DIRECT FACTOR XA INHIBITOR WITH THROMBIN INHIBITORS, WARFARIN AND CLOPIDOGREL
Trabetti E.	-	INCREASED ARACHIDONIC/LINOLEIC RATIO AND A POLYGENIC MODEL OF DESATURASE POLYMORPHIMS ARE ASSOCIATED WITH INCREASED RISK OF CORONARY ARTERY DISEASE
Tracz W.	-	ASSOCIATION BETWEEN ASPIRIN RESISTANCE AND INCREASED THROMBIN GENERATION AT THE SITE OF MICROVASCULAR INJURY: THE EFFECT OF SIMVASTATIN
	-	REDUCED CLOT PERMEABILITY AND SUSCEPTIBILITY TO LYSIS IN PATIENTS WITH ACUTE CORONARY SYNDROME: EFFECTS OF INFLAMMATION AND OXIDATIVE STRESS
	-	FOLIC ACID ADMINISTRATION AND PLATELET ACTIVATION AT THE SITE OF MICROVASCULAR INJURY IN SUBJECTS WITH ELEVATED TOTAL HOMOCYSTEINE
	-	NO DECREASE IN THROMBIN FORMATION AT THE SITE OF MICROVASCULAR INJURY IN PATIENTS TREATED WITH CLOPIDOGREL
Träger I.	-	DETERMINATION OF THE ANTICOAGULANT ACTIVITY OF IDRAPARINUX IN PATIENTS BY PROTHROMBIN-INDUCED CLOTTING TIME AND HEPTEST
Traisci G.	-	DETERMINANTS OF PLATELET ACTIVATION IN HEART FAILURE
Traivaree C.	-	THE EFFICACY AND SAFETY OF ANTITHROMBIN CONCENTRATE IN CHILDREN RECEIVING HEPARIN INFUSIONS
	-	OUTCOMES OF THROMBOLYSIS FOR REPEATED COURSES OF SYSTEMIC TISSUE PLASMINOGEN ACTIVATOR FOR INTRAVASCULAR THROMBOSIS IN CHILDREN
	-	COMPARISON OF SYSTEMIC TISSUE PLASMINOGEN ACTIVATOR FOR VENOUS THROMBI AND ARTERIAL THROMBI IN CHILDREN
	-	THE EFFICACY AND SAFETY OF FRESH FROZEN PLASMA (FFP) AND SYSTEMIC TISSUE PLASMINOGEN ACTIVATOR FOR TREATMENT OF INTRAVASCULAR THROMBOSIS IN INFANTS
Tran S.	-	DYSREGULATION OF ALTERNATIVE SPLICING OF COAGULATION FACTOR V RESULTS IN BLEEDING DISORDER, EAST TEXAS TYPE (OMIM 605913)
Tran H.A.	-	COMPARISON OF IMPEDANCE WHOLE BLOOD AGGREGATION AND OPTICAL PLATELET-RICH PLASMA AGGREGATION TO MEASURE THE ANTIPLATELET EFFECT OF ASPIRIN IN HEALTHY CONTROLS AND IN PATIENTS WITH PERIPHERAL ARTERY DISEASE (PAD)
Tran-Fadulu V.	-	DYSREGULATION OF ALTERNATIVE SPLICING OF COAGULATION FACTOR V RESULTS IN BLEEDING DISORDER, EAST TEXAS TYPE (OMIM 605913)
Tranholm M.	-	EFFECT OF MICROSPHERE EMBOLI ON THE VENTILATION-PERFUSION RELATIONSHIP IN THE RABBIT - A PILOT STUDY
	-	WHOLE BLOOD CLOTTING TIME (WBCT) COMPARED TO IN VIVO DOSE RESPONSE OF RFVIIA IN FVIII-KO MICE
	-	PROSPECTIVE DESIGN OF A NEW, OBJECTIVE SCORING SYSTEM FOR IDENTIFYING DISSEMINATED INTRAVASCULAR COAGULATION IN DOGS A SPONTANEOUS ANIMAL MODEL
	-	NEEDLE INDUCED HAEMARTHROSIS: A MURINE MODEL OF HEMOPHILIC SYNOVITIS
	-	EFFECT OF GLYCOPEGYLATION ON THE PHARMACOKINETIC PROPERTIES OF FVIIA
	-	CLEARANCE OF FACTOR VIIA (FVIIA) IN THE MOUSE IS NOT AFFECTED BY ALPHA 2-MACROGLOBULIN GENE DELETION OR ACTIVE-SITE BLOCKAGE OF FVIIA
Tratar G.	-	T1-WEIGHTED MAGNETIC RESONANCE IMAGING DIFFERENTIATES PLATELETS IN PULMONARY EMBOLI EX VIVO
Trbojevic B.	-	INVESTIGATION OF ACQUIRED VON WILLEBRAND'S SYNDROME IN PATIENTS WITH HYPOTHYROIDISM
Treanor P.	-	DISCOVERY OF A POTENT, DIRECT THROMBIN INHIBITING APTAMER
Tregouet D.A.	-	PAI-1 GENE HAPLOTYPES ARE ASSOCIATED WITH MYOCARDIAL INFARCTION OCCURRENCE IN NON SMOKERS: THE HIFMECH STUDY
Trellu M.	-	BIOEQUIPOTENCY OF IDRAPARINUX AND BIOTINYLATED IDRAPARINUX AFTER SINGLE DOSE IN HEALTHY SUBJECTS
	-	NEUTRALIZATION BY AVIDIN OF ANTICOAGULANT ACTIVITY OF BIOTINYLATED IDRAPARINUX, THE FIRST AND UNIQUE REVERSIBLE LONG-ACTING ANTICOAGULANT
Tremoli E.	-	TISSUE FACTOR INDUCTION BY PROTEASE-ACTIVATED RECEPTOR-1 REQUIRES INTACT CAVEOLIN-ENRICHED MEMBRANE MICRODOMAINS IN HUMAN ENDOTHELIAL CELLS
	-	PAR-1 AND PAR-2 ACTIVATION MEDIATES TISSUE FACTOR INDUCTION IN ENDOTHELIAL CELLS THROUGH A REDOX-SENSITIVE SIGNALING PATHWAY
	-	DIFFERENT PATTERN OF TF EXPRESSION IN PLATELETS, LEUKOCYTES AND AGGREGATES OF CAD PATIENTS
	-	ASSOCIATION OF TISSUE FACTOR A-603G GENOTYPE WITH CAROTID INTIMA-MEDIA THICKNESS IN SUBJECTS IN CARDIOVASCULAR RISK PREVENTION
	-	TOBACCO SMOKE COOPERATES WITH INTERLEUKIN-1B TO ALTER B-CATENIN TRAFFICKING IN VASCULAR ENDOTHELIUM RESULTING IN INCREASED PERMEABILITY AND INDUCTION OF CYCLOOXYGENASE-2 EXPRESSION IN VITRO AND IN VIVO
	-	BIOCHEMICAL AND MECHANICAL PROPERTIES OF INTRALUMINAL THROMBUS FROM HUMAN ABDOMINAL AORTIC ANEURYSM
	-	CYCLOOXYGENASE-2 IS CRITICAL FOR HYDROGEN PEROXIDE-MEDIATED WOUND REPAIR IN HUMAN ENDOTHELIAL CELLS
	-	E-SELECTIN AND TFPI ARE ASSOCIATED WITH CAROTID INTIMA-MEDIA THICKNESS IN STABLE CORONARY PATIENTS: THE BASELINE FINDINGS OF THE MIAMI STUDY
	-	ROSUVASTATIN EXERTS RENOPROTECTIVE EFFECTS IN STROKE-PRONE RATS BY MODULATING THE PLASMINOGEN/PLASMIN SYSTEM AND THE METALLOPROTEASES EXPRESSION
	-	EVALUATION OF THE EFFECT OF TWO DIFFERENT DOSES OF ASPIRIN IN PATIENTS UNDERGOING CABG
	-	PARACRINE UP-REGULATION OF MONOCYTE CYCLOOXYGENASE-2 BY PLATELETS: ROLE OF TGF-BETA1
	-	PROTEOME OF ENDOTHELIAL CELL-DERIVED PROCOAGULANT MICROPARTICLES
Treskes M.	-	COAGULATION PARAMETERS OF THE ISTH OVERT DIC SCORE: FIRST, THEIR DISTRIBUTION
Tressel P.	-	COVALENT ANTITHROMBIN-HEPARIN COMPLEX REDUCES BRAIN EMBOLI DURING HYPOTHERMIC CARDIOPULMONARY BYPASS IN PIGS
Treumann A.	-	A TAILOR-MADE PEPTIDE-AFFINITY COLUMN TO IDENTIFY NOVEL BINDING PARTNERS FOR A CYTOPLASMIC MOTIF OF THE PLATELET INTEGRIN ALPHA IIB
Treutwein J.	-	THE PTT IS NOT ENOUGH PREOPERATIVE COAGULATION SCREENING IN CHILDREN
Trevisan M.	-	INTERLEUKINS GENES TAG-SNP HAPLOTYPES AND RISK OF MYOCARDIAL INFARCTION: A POPULATION BASED CASE-CONTROL STUDY
	-	TISSUE FACTOR GENE TAG-SNPS AND HAPLOTYPES AND THE RISK OF MYOCARDIAL INFARCTION
Trichet C.	-	FACTOR V LEIDEN (G1691A) AND PROTHROMBIN (G20210A) GENOTYPING BY HIGH-RESOLUTION MELT ANALYSIS (HRM) AND SYTO 9 FLUORESCENT DYE ON THE ROTOR-GENE 6000 HRM
Trifiro E.	-	INFLUENCE OF PLATELET GP6 HAPLOTYPES (GP6A AND GP6B)
Trifirò E.	-	PERSISTENT TXA2 PRODUCTION IN PATIENTS CHRONICALLY TREATED WITH ASPIRIN: RESIDUAL COX-1 ACTIVITY OR COX-2 ACTIVATION?
Trimarchi T.	-	THROMBOPROPHYLAXIS IN HIGH-RISK ADOLESCENT INPATIENTS
Trimnell A.	-	VARIEGIN, A NOVEL CLASS OF THROMBIN INHIBITOR FROM THE SALIVARY GLAND EXTRACT OF THE HARD TICK AMBLYOMMA VARIEGATUM
Trimpert C.	-	HEPARIN-INDUCED THROMBOCYTOPENIA (HIT) AND DILATED CARDIOMYOPATHY (DCM) - PARALLELS IN THE PATHOGENESIS OF TWO SEVERE IMMUNE MEDIATED CARDIOVASCULARE DISORDERS
Trinquart L.	-	DECREASED ADAMTS-13 IS ASSOCIATED WITH A POOR PROGNOSIS IN SEPSIS-INDUCED ORGAN FAILURE
Tripathy A.	-	ANALYSIS OF AFFINITY OF KNOB-HOLE INTERACTIONS RESPONSIBLE FOR FIBRIN POLYMERIZATION
Tripodi A.	-	INTERFERENCE OF FACTOR V LEIDEN ON PROTEIN S ACTIVITY. EVALUATION OF A NEW PROTHROMBIN TIME-BASED ASSAY
	-	QUALITY ASSESSMENT OF COAGUCHEK MONITORS: COMPARATIVE ANALYSIS OF THE ECAA AND CONVENTIONAL EXTERNAL QA
	-	A NATIONAL FIELD STUDY OF QUALITY ASSESSMENT (QA) OF COAGUCHEK MONITORS
	-	EXTERNAL QUALITY CONTROL FOR THE COAGUCHEK INR MEASUREMENT IMPORTANT TO CONTROL TEST STRIP QUALITY: EVIDENCE FOR LIMITED PROPORTIONAL DIFFERENCES
	-	EVALUATION OF THE THROMBOELASTOMETRY
	-	THE NATURAL HISTORY OF D-DIMER LEVELS IN SUBJECTS WITH NEGATIVE D-DIMER AFTER SUSPENSION OF ORAL ANTICOAGULATION FOR A FIRST EPISODE OF VENOUS THROMBOEMBOLISM: THE PROSPECTIVE OBSERVATIONAL PROLONG II STUDY
	-	THE INTERNATIONAL NORMALIZED RATIO TO PRIORITIZE PATIENTS FOR LIVER TRANSPLANTATION. PROBLEMS AND SOLUTIONS
	-	THE ROLE OF D-DIMER AS A RISK FACTOR FOR OCCULT CANCER AND CARDIOVASCULAR EVENTS AFTER ANTICOAGULATION WITHDRAWAL FOR A FIRST IDIOPATHIC DEEP VEIN THROMBOSIS IN THE PROLONG STUDY
	-	COST-EFFECTIVENESS OF COMPUTER-ASSISTED ANTICOAGULANT DOSAGE
	-	DIFFERENT CUT-OFF VALUES OF THREE D-DIMER (DD) TESTS TO ESTABLISH DURATION OF ORAL ANTICOAGULATION TREATMENT (OAT) AFTER A VENOUS THROMBOEMBOLISM (VTE)
	-	LOCAL ISI CALIBRATION AND "DIRECT INR" IN CORRECTION OF REPORTED INTERNATIONAL NORMALISED RATIOS: AN INTERNATIONAL STUDY
	-	THE ENDOGENOUS THROMBIN POTENTIAL AND THE RISK OF VENOUS THROMBOEMBOLISM
	-	COST-EFFECTIVENESS OF COMPUTER-ASSISTED ANTICOAGULANT DOSAGE CLINICAL STUDY
	-	THROMBIN GENERATION IN SEVERE HEMOPHILIACS WITH DIFFERENT CLINICAL PHENOTYPE
Triscott M.	-	SELECTIVE ENHANCEMENT OF PROTEIN S REAGENT SENSITIVITY BY BOVINE GAMMA GLOBULIN
	-	ASSIGNMENT AND VALIDATION OF INR CONTROL AND CALIBRATOR SETS FOR LOCAL CALIBRATION OF INR
	-	THROMBOPATH KIT HAS INCREASED SENSITIVITY TO PROTHROMBOTIC LUPUS ANTICOAGULANTS
	-	THE IMPACT OF PHOSPHOLIPID COMPOSITION ON THE INTERFERENCE CAUSED BY THE ANTIBIOTIC DAPTOMYCIN IN THROMBOPLASTIN REAGENTS
	-	THROMBOPATH KIT CORRELATES BETTER WITH FREE PROTEIN S TO PROTHROMBIN RATIO AND FUNCTIONAL PS THAN WITH FREE PS
	-	MULTIFACTORIAL ANALYSIS USING FOUR PHOSPHOLIPIDS TO THOROUGHLY INVESTIGATE CONTROL OF THROMBOPLASTIN PROPERTIES AND SENSITIVITIES
	-	ILPCA, A RECOMBINANT PC ACTIVATOR SUCCESSFULLY USED TO FORMULATE AN AUTOMATED PC CHROMOGENIC ASSAY IN LIQUID FORMAT
	-	THE SYNERGISTIC EFFECTS OF SYNTHETIC PHOSPHOLIPIDS AND RECOMBINANT TISSUE FACTOR IN THE OPTIMIZATION OF A PROTEIN S ASSAY SENSITIVITY
	-	LIQUID HEPARIN ASSAY: RAPID MONITORING OF CLINICALLY USED HEPARINS
	-	EVALUATION OF VARYING CALCIUM CONCENTRATIONS TO IDENTIFY ANTIB2-GLYCOPROTEIN I LUPUS ANTICOAGULANTS WITH A SILICA CLOTTING TIME METHOD FOR LUPUS ANTICOAGULANT TESTING
	-	OPTIMIZATION OF COAGULATION FACTOR ASSAYS FOR IMPROVED ACCURACY OVER AN EXTENDED LINEAR RANGE
Trobisch H.	-	FIVE NOVEL MUTATIONS IN F13B GENE RESULTING IN MILD FXIII DEFICIENCY
	-	PAEDIATRIC REFERENCE RANGES FOR COAGULATION DIAGNOSTICS
	-	NORMAL VALUES FOR FACTOR VII ACTIVITY IN NORMAL PREGNANCY AND IN THE PREGNACY OF WOMEN WITH CONGENITAL FACTOR VII DEFICIENCY
Troisi N.	-	PROTEIN Z PLASMA LEVELS IN DIFFERENT LOCALIZATIONS OF ATHEROSCLEROTIC DISEASE
Troost M.M.	-	HEART-TYPE FATTY ACID BINDING PROTEIN IS PREDICTIVE FOR MORTALITY IN PATIENTS WITH ACUTE PULMONARY EMBOLISM
Trossaert M.	-	INFLUENCE OF THE SOURCE OF PHOSPHOLIPIDS FOR APTT-BASED FIX ASSAYS AND POTENTIAL CONSEQUENCES FOR THE DIAGNOSIS OF MILD/MODERATE HAEMOPHILIA B
Trossaërt M.	-	INFLUENCE OF PHOSPHOLIPID SURFACE AND CONCENTRATION IN THROMBOGRAPHY
Trossaert M.	-	SUCCESSFUL TREATMENT OF HIGH TITRE FACTOR VIII (FVIII) INHIBITOR IN TWO PATIENTS WITH MILD AND MODERATE HAEMOPHILIA A WITH RITUXIMAB ALONE
	-	CAN THROMBIN GENERATION BE HELPFUL TO EVALUATE THE BLEEDING PHENOTYPE IN MILD HEMOPHILIA A WITH FACTOR VIII ASSAY DISCREPANCY?
Trummal K.	-	PLATELET AGGREGATION INHIBITING COMPONENTS FROM VIPERA LEBETINA SNAKE VENOM
Tsai M.	-	THE PROTECTIVE ROLE OF PROTEIN C IN ENDOTOXIN-INDUCED SHOCK
Tsai W.	-	PREVALENCE OF VON WILLEBRAND'S DISEASE IN PREMENOPAUSAL WOMEN WITH IRON DEFICIENCY ANEMIA AND MENORRHAGIA
Tsai H.	-	AN IAP RETROTRANSPOSON IN MOUSE ADAMTS13 GENE GENERATES ADAMTS13 VARIANTS LESS EFFECTIVE IN CLEAVING VWF MULTIMERS
Tsai W.	-	GENETIC DEFECT DETECTION OF HEMOPHILIA A BY LONG RANGE POLYMERASE CHAIN REACTION AND DENATURING HIGH-PERFORMANCE LIQUID CHROMATOGRAPHY
	-	GENETIC DEFECT DETECTION OF HEMOPHILIA A BY LONG RANGE POLYMERASE CHAIN REACTION AND DENATURING HIGH-PERFORMANCE LIQUID CHROMATOGRAPHY
Tsai I.	-	OCCURRENCE, SUBSTRATE SPECIFICITY, CLONING AND BIOINFORMATIC ANALYSES OF HEMORRHAGIC P-III PROTEASE OF RUSSELL'S VIPER VENOM
Tsai S.	-	OCCURRENCE, SUBSTRATE SPECIFICITY, CLONING AND BIOINFORMATIC ANALYSES OF HEMORRHAGIC P-III PROTEASE OF RUSSELL'S VIPER VENOM
Tsakiris D.	-	EVALUATION OF THE COAGUCHEK XS PLUS SYSTEM IN A SWISS COMMUNITY SETTING
Tsao D.	-	IDENTIFICATION OF POTENT CYCLIC PEPTIDES THAT BIND TO PLATELET GLYCOPROTEIN IB ALPHA AND SELECTIVELY INHIBIT VON WILLEBRAND FACTOR DEPENDENT HIGH-SHEAR PLATELET AGGREGATION
Tschudi M.	-	DOSING LEPIRUDIN IN PATIENTS WITH HEPARIN-INDUCED THROMBOCYTOPENIA AND VARIOUS DEGREES OF RENAL FUNCTION IMPAIRMENT
Tseng C.	-	THE NEGATIVE EFFECT OF LEVOBUPIVACAINE ON COLLAGEN-INDUCED PLATELET AGGREGATION
	-	PLATELET PROTEIN DISABLED-2 IS REQUIRED FOR EMBRYONIC STEM CELL-DERIVED MESODERM FORMATION AND MEGAKARYOCYTIC DIFFERENTIATION
Tseng H.	-	KNOCKOUT OF THE THROMBOXANE SYNTHASE CAUSES REDUCTION OF VASCULAR SMOOTH MUSCLE CELL PROLIFERATION AND MIGRATION IN AN ARTERY INJURY MODEL
Tseng C.	-	THE RGD-CONTAINING PEPTIDE DERIVED FROM PLATELET DISABLED-2 INHIBITS DU145 PROSTATE CANCER CELL-INDUCED PLATELET AGGREGATION
Tsibikov M.N.	-	PEPTIDE MECHANISMS REGULATION OF HEMOSTASIS IN PURULENT SURGICAL INFECTION
Tsironi M.	-	CIRCULATING LEVELS OF ADHESION MOLECULES AND MARKERS OF ENDOTHELIAL DYSFUNCTION IN ACUTE INFLAMMATION INDUCED BY PROLONGED BRISK EXERCISE: RAPID ENDOTHELIAL RECOVERY AND POTENTIAL BENEFICIAL EFFECTS
Tsoucala C.	-	PRELIMINARY RESULTS ON EFFECTIVENESS AND SAFETY OF COMBINED ANTICOAGULANT AND ANTIPLATELET THERAPY
	-	DOES ADMINISTRATION OF LANSOPRAZOLE AFFECT ASA ANTIPLATELET FUNCTION IN HIGH RISK CARDIOVASCULAR PATIENTS? PRELIMINARY RESULTS
	-	SAFETY AND EFFICACY OF TINZAPARIN ADMINISTRATION DURING PREGNANCY
	-	COAGUCHEK XS IN COMPARISON TO BCS ANALYZER. RESULTS IN AN OUTPATIENT ANTICOAGULATION CLINIC, FOCUSED IN METAL VALVE DISEASE
	-	CONTRIBUTION OF ROTATION THROMBOELASTOGRAPHY (RT) IN PERIOPERATIVE MANAGEMENT OF PATIENTS WITH GLAZMANN'S THROMBASTHENIA (GT)
Tsuchida K.	-	THE RELATIONSHIP BETWEEN STRANDING IN CARS AND DVT AFTER THE MIDDLE NIIGATA PREFECTURE EARTHQUAKE 2004
Tsuda T.	-	GENETIC ABLATION OF JAM-A IMPAIRS SURVIVAL AFTER MYOCARDIAL INFARCT
Tsuda H.	-	PHYTOESTROGENS DOWN-REGULATE PROTEIN S EXPRESSION IN HEPG2 CELLS
Tsuji H.	-	ONE-THIRD OF JAPANESE PATIENTS WITH DEEP VEIN THROMBOSIS CARRIED THE GENETIC MUTATIONS IN PROTEINS S, C AND ANTITHROMBIN GENES: THE SUB-GROUP STUDY OF BLOOD COAGULATION ABNORMALITY, THE STUDY GROUP OF RESEARCH ON MEASURES FOR INTRACTABLE DISEASES IN JAPAN
Tsuji M.	-	Pharmacokinetics of a mixture of FVIIa and FX in rats
Tsuji N.	-	COMPARISON OF ANTITHROMBOTIC PROPERTIES OF A DIRECT FXA INHIBITOR, DU-176B, WITH AN ANTITHROMBIN DEPENDENT FXA INHIBITOR, FONDAPARINUX, IN A CAPILLARY PERFUSION CHAMBER THROMBOSIS MODEL
	-	EFFECTS OF DU-176B, A NOVEL DIRECT FACTOR XA INHIBITOR, ON PROTHROMBINASE ACTIVITY AND PLATELET AGGREGATION IN VITRO
Tsuji H.	-	A LARGE DELETION OF THE PROS1 GENE IN A DEEP VEIN THROMBOSIS PATIENT WITH PROTEIN S DEFICIENCY
Tsujikawa A.	-	DOUBLE MUTATION, A 2-BP DELETION AND VAL 211ILE, IN THE BLOOD COAGULATION FACTOR IX GENE IN A PATIENT WITH SEVERE HEMOPHILIA B
	-	CONTINUOUS INFUSION OF VON WILLEBRAND FACTOR/FACTOR VIII CONCENTRATE IN PATIENTS WITH CONGENITAL VON WILLEBRAND DISEASE
Tsukahara R.	-	THE PLAQUE LIPID LYSOPHOSPHATIDIC ACID STIMULATES PLATELETS NOT THROUGH THE LPA1, LPA2 AND LPA3 RECEPTOR
Tsurupa G.	-	DIRECT EVIDENCE OF SPECIFIC INTERACTIONS OF FIBRINOGEN ALPHA C REGIONS WITH THE CENTRAL E REGION AND WITH EACH OTHER
Tsybikov N.N.	-	POSSIBLE MECHANISMS OF THE DEVELOPMENT OF DIC SYNDROME
Tucker E.I.	-	THE THROMBIN MUTANT W215A/E217A ACTS AS A PLATELET ANTAGONIST THROUGH INHIBITION OF THROMBIN ACTIVATION AND GPIB BINDING TO VWF
	-	PROTEIN C ACTIVATOR (PCA) TREATMENT IMPROVES THE NEUROLOGICAL OUTCOME OF EXPERIMENTAL THROMBOTIC ISCHEMIC STROKE IN MICE
	-	FACTOR XI MEDIATES PLATELET LAMELLIPODIA FORMATION AND TETHERING AND ROLLING UNDER SHEAR CONDITIONS
	-	HIGH SENSITIVITY THROMBOGENIC MARKER DETECTION IN THE INTRALUMINAL BOUNDARY LAYER
Tucker K.L.	-	TACHYKININS AND THE NEUROKININ RECEPTOR 1 ARE REQUIRED FOR PLATELET THROMBUS FORMATION
Tucker E.I.	-	PROTEIN C ACTIVATOR (PCA) INTERRUPTION OF THROMBUS PROPAGATION WITHOUT ANTIHEMOSTATIC SIDE EFFECT IN PRIMATES
	-	REDUCED MORTALITY OF PERITONEAL SEPSIS IN FACTOR XI DEFICIENT MICE
Tuddenham E.G.	-	CATASTROPHIC ANTIPHOSPHOLIPID SYNDROME PRESENTING WITH ISOLATED ANTI-BETA2 GLYCOPROTEIN I ANTIBODY POSITIVITY
	-	THROMBIN GENERATION & ROTEM TESTS IN PREGNANCY: POTENTIAL FOR MONITORING ADEQUACY OF LOW MOLECULAR WEIGHT HEPARIN ADMINISTRATION
	-	THROMBIN GENERATION TEST (TGT) AND ROTATIONAL THROMBOELASTOGRAPHY (ROTEM) AND ITS USE IN ASSESSING SEVERE HAEMOPHILIA A PHENOTYPE
Tudev M.	-	ANTIPLATELET ACTIVITY OF FENOFIBRATE, A PPARALPHA AGONIST, WAS MEDIATED BY BLOCKING OF CYTOSOLIC CALCIUM MOBILIZATION AND THROMBOXANE A2 RECEPTOR
Tufano A.	-	BUDD-CHIARI SYNDROME IN A PAROXYSMAL NOCTURNAL HEMOGLOBINURIA PATIENT WITH PREVIOUS CEREBRAL VENOUS THROMBOSIS
	-	PREDISPOSING FACTORS IN PATIENTS WITH EARLY-ONSET CEREBRAL VEIN THROMBOSIS
	-	DESMOPRESSIN IN PATIENTS WITH CONGENITAL DISORDERS OF PRIMARY HAEMOSTASIS: FOUR YEAR PROSPECTIVE EVALUATION
	-	LOW INSULIN-LIKE GROWTH FACTOR (IGF) I, IGF BINDING PROTEIN-3 AND ACID LABILE SUBUNIT (ALS) LEVELS IN YOUNG ISCHEMIC STROKE: A PROSPECTIVE CASE-CONTROL STUDY
	-	ACQUIRED AND INHERITED PREDISPOSING CONDITIONS IN PATIENTS WITH RETINAL VEIN OCCLUSION
	-	RIGHT-TO-LEFT SHUNT, ATRIAL SEPTAL ANEURYSM AND THROMBOPHILIA IN PATIENTS WITH CRYPTOGENIC STROKE OR TIA VERSUS THOSE WITH VENOUS THROMBOEMBOLISM
Tulpule S.	-	UNEXPECTED FINDING OF RAISED UNDERCARBOXYLATED FII (PIVKA-II) IN FVII DEFICIENCY
Tunstead J.R.	-	NATURALLY OCCURRING TF VARIANTS ARE PRESENT IN BLOOD OF FVB/N MICE: THE MKR MODEL OF TYPE 2 DIABETES IS WELL SUITED FOR DEVELOPMENT OF A TF-BASED MODEL OF DIABETIC THROMBOPHILIA
Turdó K.	-	BIOLOGICAL AND CLINICAL RESPONSE TO DESMOPRESSIN IN CHILDREN WITH VON WILLEBRAND DISEASE
Turecek P.L.	-	BIOCHEMICAL AND FUNCTIONAL CHARACTERIZATION OF A RVWF DRUG CANDIDATE PRODUCED UNDER SERUM-FREE CONDITIONS
	-	PHARMACOKINETICS (PK) OF RVWF IN DOGS AND MICE WITH SEVERE VWD
	-	SERIAL MONITORING OF ADAMTS13- AND VWF-RELATED PARAMETERS IN PATIENTS WITH THROMBOTIC THROMBOCYTOPENIC PURPURA: PREDICTION OF RESPONSE TO THERAPY, RISK OF RELAPSE, AND LONG-TERM COURSE
	-	PRIMARY HEMOSTATIC EFFICACY OF RVWF IN A NOVEL MODEL OF VASCULAR INJURY IN MICE WITH SEVERE VWF DEFICIENCY
Turecek P.	-	THE EFFECT OF APCC AND PCC ON THE GENERATION OF THROMBIN IN HAEMOPHILIA A PATIENTS WITH FVIII INHIBITOR: A CROSS-OVER PHARMACOKINETIC STUDY
Turecek P.L.	-	BIOCHEMICAL AND FUNCTIONAL CHARACTERIZATION OF CHEMICALLY MODIFIED RECOMBINANT VON WILLEBRAND FACTOR (RVWF) AS A CARRIER PROLONGING SURVIVAL OF RFVIII IN HEMOPHILIA A KNOCK-OUT MICE
Turello M.	-	SAFETY AND EFFICACY OF NADROPARIN FOR THE MANAGEMENT OF VENOUS THROMBOEMBOLISM OR THROMBOPHILIA IN PREGNANCY
	-	PROTHROMBOTIC FACTORS AND OXIDATIVE STRESS MARKERS IN A TYPE 2 DIABETES POPULATION
Turenhout E.A.M.	-	HUMAN VH1-69 GERMLINE GENE ENCODED ANTI-SPACER DOMAIN ANTIBODIES THAT DEVELOP IN PATIENTS WITH ACQUIRED TTP INTERFERE WITH THE BINDING OF ADAMTS13 TO VWF
Turgut B.	-	IS PLATELET HYPERREACTIVITY DEFINING STICKY PLATELET SYNDROME A GLOBAL PHENOMENON? THE STUDY OF DETERMINATON OF NORMAL VALUES IN TURKISH HEALTHY SUBJECTS
Turgut N.	-	THE EFFECT OF EXERCISE ON FIBRINOLYTIC AND COAGULATION SYSTEMS IN HEALTHY VOLUNTEERS
Turgut B.	-	INCIDENCE OF ANTI-HEPARIN/PLATELET FACTOR 4 (AHPF4) ANTIBODIES AND HEPARIN-INDUCED THROMBOCYTOPENIA (HIT) IN MEDICAL PATIENTS
Turkkan E.	-	RADIOSYNOVECTOMY WITH YTRIUM-90 AND RHENIUM-186 IN HEMOPHILIC ARTHROPATY
Turman S.	-	EFFECT OF RECOMBINANT FACTOR XIII-A ON ENDOTHELIAL BARRIER FUNCTION
Turpie A.G.G.	-	UNFRACTIONATED HEPARIN (UFH) OR LOW-MOLECULAR-WEIGHT HEPARIN (LMWH) AS PERIOPERATIVE BRIDGING THERAPY IN PATIENTS WITH MECHANICAL HEART VALVES (MHVS) ON LONG-TERM ORAL ANTICOAGULANTS (OAC): RESULTS FROM THE REGIMEN REGISTRY
	-	PREVENTION OF VENOUS THROMBOEMBOLISM VIA PARTIAL FACTOR IXA INHIBITION
Turpie A.G.	-	LATE BREAKING CLINICAL TRIAL: RIVAROXABAN AN ORAL, DIRECT FACTOR XA INHIBITOR FOR THE PREVENTION OF VENOUS THROMBOEMBOLISM IN TOTAL KNEE REPLACEMENT SURGERY: RESULTS OF THE RECORD 3 STUDY - LATE BREAKING
Turpie A.	-	THROMBOEMBOLISM AND BLEEDING OUTCOMES OF LOW-MOLECULAR-WEIGHT HEPARIN BRIDGING THERAPY DURING PERI-PROCEDURE WARFARIN INTERRUPTION: PATIENT-LEVEL POOLED DATA OF FOUR COHORT STUDIES
Turpie A.G.	-	FONDAPARINUX 1.5 MG ONCE DAILY IN THE PROPHYLAXIS OF VENOUS THROMBOEMBOLISM (VTE): EFFICACY AND SAFETY IN RENALLY-IMPAIRED PATIENTS FROM A DOSE-RANGING STUDY IN MAJOR ORTHOPEDIC SURGERY
	-	EFFICACY OF FONDAPARINUX IN MEDICAL PATIENTS WITH RESTRICTED MOBILITY ACCORDING TO THE ENDPOINT PROPOSED BY THE EUROPEAN COMMITTEE FOR PROPRIETARY MEDICINAL PRODUCTS (CPMP)
	-	EFFECT OF FONDAPARINUX 2.5 MG ONCE DAILY ON ALL CAUSE MORTALITY: A META-ANALYSIS OF THROMBOPROPHYLAXIS TRIALS
	-	PHARMACOKINETICS (PK) OF SUBCUTANEOUS FONDAPARINUX 1.5 MG IN PATIENTS WITH MODERATE RENAL IMPAIRMENT (MRI)
	-	LONG TERM OUTCOMES OF DEEP-VEIN THROMBOSIS IN ASIA AFTER MAJOR ORTHOPEDIC SURGERY: THE AIDA EXTENSION STUDY
	-	CLINICAL EFFICACY AND SAFETY OF FONDAPARINUX IN PATIENTS WITH CONGESTIVE HEART FAILURE (CHF): A SUBANALYSIS OF THE RANDOMIZED ARTEMIS TRIAL
	-	EVALUATION OF THE FACTOR XA (FXA) INHIBITOR, PRT054021 (PRT021), AGAINST ENOXAPARIN IN A RANDOMIZED TRIAL FOR THE PREVENTION OF VENOUS THROMBOEMBOLIC EVENTS AFTER TOTAL KNEE REPLACEMENT (EXPERT)
Turpie A.G.G.	-	LACK OF EFFECT ON MARKERS OF THROMBIN GENERATION AND FIBRINOLYSIS BY PARTIAL FACTOR IXA INHIBITION FOLLOWING HIP FRACTURE SURGERY
	-	LATE BREAKING CLINICAL TRIAL: EXTENDED-DURATION VENOUS THROMBOEMBOLISM (VTE) PROPHYLAXIS IN ACUTELY ILL MEDICAL PATIENTS WITH RECENT REDUCED MOBILITY: THE EXCLAIM STUDY
Turundaevskaja O.V.	-	APPLICATION OF DISCRETE PLASMAPHERESIS IN TREATMENT OF DISSEMINATED INTRAVASCULAR COAGULATION SYNDROME
Turundaevskaya O.V.	-	ANTITHROMBIN III IN COMPARISON WITH FRESH FROZEN PLASMA IN THE TREATMENT OF DISSEMINATED INTRAVASCULAR COAGULATION ACCOMPANIED BY ANTITHROMBIN III DEFICIENCY
Tushuizen M.E.	-	SIMVASTATIN-INDUCED ENDOTHELIAL CELL DETACHMENT AND MICROPARTICLE RELEASE ARE PRENYLATION DEPENDENT
Tuttle A.	-	THE PREVALENCE OF SYMPTOMATIC VON WILLEBRAND DISEASE (VWD) IN PRIMARY CARE PRACTICE
Tveit A.	-	PLASMINOGEN ACTIVATOR INHIBITOR-1 ACTIVITY PREDICTS RHYTHM OUTCOME AFTER ELECTRICAL CARDIOVERSION FOR ATRIAL FIBRILLATION
	-	SAFETY AND TOLERABILITY OF THE ORAL DIRECT THROMBIN INHIBITOR AZD0837 IN PREVENTION OF STROKE AND OTHER THROMBOEMBOLIC COMPLICATIONS ASSOCIATED WITH ATRIAL FIBRILLATION (AF)
Tydell J.	-	EVALUATION OF ALLOSTERIC INHIBITORS OF PAR1 ON PLATELET ACTIVATION
Tyurin K.V.	-	STABILITY OF COAGULATION SYSTEM BASELINE STATE: A MATHEMATICAL MODEL
	-	STUDY OF RECOMBINANT FACTOR VIIA ACTION MECHANISM: A MATHEMATICAL MODEL
	-	CLOT FORMATION AS TREATMENT METHOD FOR PATHOLOGICAL FOCUS: A MATHEMATICAL MODEL
	-	STABILITY OF COAGULATION SYSTEM BASELINE STATE: A MATHEMATICAL MODEL
	-	MECHANISM OF BLOOD COAGULATION TRIGGERING: A MATHEMATICAL MODEL
Tzortzatos G.	-	DALTEPARIN SHORTENS HUMAN LABOR
Tzouroutis J.	-	THE STABILITY OF A PLASMA-DERIVED FACTOR VIII PRODUCT DURING SIMULATED CONTINUOUS INFUSION

| ISTH 2009